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Abstract 
 
Osseointegration has been defined as a direct bone-to-implant contact without interposed 
soft tissue. A rigid, functional fixation of dental implants within the host bone site achieved 
by osseointegration is necessary to provide long-term anchorage with the ability to support 
masticatory function. The osseointegration process and consequent clinical success of dental 
implants becomes more challenging in compromised clinical situations like osteoporosis. 
However, researchers still do not fully understand the biological mechanisms involved in 
osseointegration, and the consequential effects of conditions like osteoporosis on this process 
remains obscure. Osteoporosis is a condition characterised by decreased bone mineral density 
and a deterioration of bone microarchitecture, resulting in compromised bone quality. 
Therefore, osteoporosis is an interesting model to study the effect of compromised bone 
quality on osseointergration. Additionally, the design, chemical characteristics and 
topography of the implant surface is known to influence peri-implant tissue healing and 
subsequent osseointegration, but whether such changes to the implant surface can overcome 
the disadvantages resulting from the osteoporotic conditions warrants further study. The aim 
of this project therefore was to observe the effects of two factors: osteoporosis and implant 
surface topography, on osseointegration.   
The ovariectomised rat is the most commonly used model to simulate human 
postmenopausal osteoporosis and has been selected for use in this study. The existing 
literature however remains inconclusive as to whether the jaw bone is affected by 
osteoporosis. .The first part of this project aimed to determine whether the rat maxilla could 
be an appropriate model for osteoporosis. In order to obtain a comprehensive understanding 
of changes in the maxilla after ovariectomy, three dimensional Micro CT together with 
histological analysis was used to analyse changes in the maxilla  8, 12, 16 and 20 weeks post 
surgery. Significant changes were observed in the rat maxillae as early as 12 weeks following 
surgery. The results also confirmed that estrogen deficiency affected the rat jawbone resulting 
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in compromised bone quality, thus establishing the rat maxilla as an appropriate model to 
explore the bone–implant healing process in osteoporosis. 
The second part of the project examined the effect of osteoporosis on dental implant 
healing. Customised titanium implants (2×3mm) were placed bilaterally in the maxillary first 
molar area of  Sprague-Dawley rats. Every animal received 2 implants. The animals were 
subsequently sacrificed up to 56 days post-surgery and resin-embedded sections of the 
implant and surrounding maxilla were prepared for histological and histomorphometric 
analyses. The percentage of bone-implant contact (%BIC) and bone area in the implant 
thread (%BA) were used to determine the effect of osteoporosis on osseointegration. The 
results showed that new bone formation around the implant increased significantly by day 14, 
as measured by the percentage of bone-to-implant contact (%BIC) and new bone area (%BA) 
in the implant thread chambers (55.1 ± 8.9% and 63.7 ± 7.7% respectively). There was a 
further significant increase between days 14 and 28 (p<0.05), however no significant 
differences were found between days 28 and 56 in either the %BIC or %BA. These results 
confirmed that the mesial root socket of the first molar in the rat maxilla is a useful model for 
dental implant research and osseointegration following implant placement.  
Successful dental implant treatment relies on the process of osseointegration whereby the 
titanium implant is bound to bone tissue without any intervening soft tissue. However the 
biological mechanisms responsible for the osseointegraton process have not been fully 
elucidated, especially with regard to the possible role of osteocytes. Moreover, the 
relationship of osteoblasts and osteocytes with the implant surface and the ultrastructural 
details of the bone-implant interface are not fully understood. A method which can visualise 
the ultrastructure of the implant-bone interface in three-dimensions (3D) would therefore be 
beneficial in facilitating the study of the relationship between bone cells and the implant 
surface.  The third part of this project has been designed to visualize the ultrastructural 
relationship between osteocytes and the titanium implant surface following osseointegration 
in vivo. Healthy female Sprague Dawley rats were used for this research. The animals were 
sacrificed 8 weeks after implantation and undecalcified tissue sections were prepared. Resin-
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cast samples were subsequently acid-etched with 37% phosphoric acid prior to examination 
using scanning electron microscopy (SEM). The results showed for the first time that 
osteocytes and their dendrites were directly connected with the implant surface. This suggests 
that osteocytes and their lacunar–canalicular network may have an important regulatory role 
in establishing and maintaining long-term osseointegration.  
Based on the above research, the final part of this project was designed to examine the 
effects of osteoporosis on osseointegration in the rat’s maxilla with different surfaced 
implants. Moderately rough surfaced implants and smoother (machined) implants were 
immediately implanted into maxillary first molar mesial sockets after tooth extraction in both 
ovariectomised (OVX) and sham-operated (SHAM) rats. The rats were sacrificed after 3, 7, 
14, 28 days healing and the bone healing process and osseointegration were evaluated by 
histological observation, scanning electron microscopy, and qPCR analysis. Osseointegration 
as measured by the percentage of bone to implant contact (%BIC), was significantly higher 
around rough surfaced implants in the OVX animals when compared to machined implants in 
OVX animals at Day 14. The %BIC in the OVX rough implant group was similar to that seen 
with both rough and smooth implants in SHAM animals at this time. By day 28 however, 
similar levels of %BIC were measured for all test groups. This suggests that the rough 
surface stimulated a more rapid osseointegration process in the OVX animals.  
To assess the possible molecular mechanism(s) responsible for this accelerated 
osseointegration on the rough surface, the level of gene expression of osteoblast, osteocyte, 
osteoclast and inflammatory markers at day 3 and 7 were examined. At day 3 the rough 
surface implant significantly increased the expression of alkaline phosphatase (ALP), 
osteocalcin (OC), alpha-1 type I collagen (COL1A), receptor activator of nuclear factor 
kappa-B ligand (RANKL), tartrate-resistant acid phosphatase (TRAP) and dentin matrix 
protein 1 (DMP1). By day 7, the expression of inflammatory markers reduced while the 
expression of the bone markers increased further overall, although there were few significant 
differences in the levels of expression comparing the rough and machined surfaces at this 
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time. These molecular results correlate with the morphological (histology and SEM) 
observations at these time points during the early healing events leading to osseointegration. 
In conclusion, osteoporosis was found to reduce the early osseointegration (as measured 
by %BIC) of machined implants. However, the rough surfaced implant appeared to trigger a 
cell response that able to compensated for the estrogen deficient conditions, resulting 
in %BIC similar to that seen in SHAM animals during early osseointegration. However, by 
the time that the peak BIC% was achieved at 28 days post placement,  this difference was not 
maintained as there was no significant difference in %BIC between the OVX and SHAM 
groups regardless of the implant surface used in the long-term (day 28).  
Conclusion 
These studies demonstrated that the rat maxilla was not only a suitable model for 
osteoporosis research, but also an appropriate model for dental implant research. Osteocytes 
and the lacunar–canalicular network were shown for the first time to be intimately involved 
in the osseointegration process, with the dendrites found to be in directly contact with the 
implant surface. Osteoporosis was found to negatively affect implant healing in the earlier 
stages, and in this process a micro-rough surfaced implant was able to compensate for the 
negative impacts of osteoporosis.   
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1.1 Background 
A dental implant is an artificial tooth root replacement, which is surgically placed into 
the jaw bone to support single or multiple tooth restorations, in order to improve the function 
and quality of life for the recipient. Commercially pure titanium (Ti) is widely used as a 
dental and orthopaedic metallic implant material due to its high biocompatibility [1, 2], good 
resistance to corrosion, and lack of inflammatory response in peri-implant tissues [2-4]. Other 
materials like tantalum[5], niobium [6], zirconium [7] and hafnium [8] have also been 
proposed as substitutes for titanium. In 2009, approximately 30,000 implants were placed in 
Australian patients ranging from 20 to 80 years of age. Implant usage has doubled in the last 
five years and the use of implants is increasing by approximately 15% each year. The dental 
implant industry has become one of the fastest growing industries in the world, and currently 
there are more than 1300 different types of implants available for clinical selection [9]. Thus, 
the replacement of missing teeth with endosseous implants for the rehabilitation of 
edentulous or partially edentulous patients has become the standard of care for tooth 
replacement [10]. 
  What is Osseointegration? 
 The major breakthrough of osseointegraton came from Per-Ingvar Brånemark. In 1952, 
the Swedish professor began his work on tissue integrated prostheses.  His objective was to 
understand the healing and reparative capacity of hard and soft tissue in order to obtain a 
predictable tissue response to implant therapy.  The studies in the early 1960’s were the first 
to describe the phenomena of osseointegraton since the titanium chambers inserted into 
animals could not be removed from the bone.  Specifically, it was noted that chambers were 
“inseparably incorporated” into the bone.  Microscopic examination revealed bone had 
actually grown into the surface pores of the titanium. In separate studies on the healing and 
anchorage stability of titanium tooth root implants, Brånemark also found that titanium 
fixtures implanted into the marrow cavity would form a shell of cortical bone directly onto 
the implant surface[11]. This work resulted in the design of titanium dental implants and the 
concept of osseointegration. 
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The success of implants is dependent on the interface between titanium and bone. 
According to the concept of osseointegration first reported by Brånemark [12], 
osseointegration has been defined as a direct bone-to-implant contact without interposed soft 
tissue (Fig.1). This kind of rigid functional fixation within the host bone site assures that 
dental implants can provide long-term anchorage to support masticatory function. Therefore, 
the widespread use of dental implants in clinical practice has profoundly changed the 
possibilities for oral rehabilitation [13]. However, the concept of "osseointegration" of 
titanium implants is mainly based on clinical evaluation and light microscopic (LM) 
observations [14]. Morphologic observation is still the preferred way to evaluate the process 
of bone formation during osseointegration. Using undecalcified ground sections for 
measuring the bone-implant-contact (BIC) or bone contact ratio (BCR) and torque tests for 
measuring the biomechanical anchorage are the two most-commonly used quantifiable 
methods for determining the amount of osseointegration [15]. 
 
       Factors influencing osseointegration of dental implants 
There are a lot of factors that influence osseointegration, amongst which systemic factors 
are considered to play an integral role. The implant and its host bone are the two major 
interacting entities, and minor changes to either entity would affect the process of bone 
formation around an implant. It is recognised that compromised bone negatively affect 
osseointegration, while a micro-rough implant surface results in superior osseointegration 
compared with a smooth surface. Many diseases and conditions may also affect bone quality. 
These include disorders of bone mineral homeostasis or imbalance of bone remodelling 
diseases such as osteoporosis, diabetes mellitus, hyperparathyroidism, Cushing’s disease, 
Paget’s disease, and collagen disorders such as osteogenesis imperfecta, Marfan syndrome, 
and drugs affecting bone quality such as glucocorticoids, chemotherapeutic agents and 
bisphosphonates, among others. [16]. Of these  diseases, osteoporosis is the most prevalent 
worldwide; it is estimated that over 200 million people worldwide have osteoporosis[17].  In 
Australia, the effects of this disease causes fractures in 50% of women and 33.33% of men 
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beyond the age of 60 years [18]. Osteoporosis causes reduced bone formation, leading to 
fractures and impaired bone healing. The relationship between osteoporosis and bone 
formation around implants is still unclear. The consensus of the ITI (International Team of 
Oral Implantology) is that there is only a weak association with the risk of implant failure, 
however, this conclusion was based on only two-case control studies[19]. This aim of this 
project is to observe the influence of osteoporosis on osseointegraton on micro-roughened 
and smooth implant surfaces.  
 
1.2 Scope of the project 
The prime focus of this project was to observe the effects of the two factors— 
osteoporosis and surface morphology on osseointegration in rat maxilla. In order to clarify it, 
we divided it into four parts. The first part was designed to evaluate bone quality in the 
posterior maxilla of ovariectomized rats in order to validate this site as an appropriate model 
to study the effect of osteoporotic changes. Micro CT and histological analysis were used to 
evaluate bone changes at different time points over a period from 8 to 20 weeks post-
ovariectomy. The study established a method to quantify the changes of intra-radicular 
alveolar bone in the posterior maxilla in an accepted rat osteoporosis model. The second part 
assessed the suitability and feasibility of placing a dental implants into the rat maxilla and to 
establish parameters to be used for dental implant research using this model. The results 
showed the mesial root socket of the first molar in the rat maxilla is a useful model for dental 
implant research. The third part was designed to visualize the ultrastructural of 
osseointegraton in vivo. The results suggested an important regulatory role for osteocytes and 
their lacunar–canalicular network in maintaining long term osseointegration. Based on the 
above research, the fourth part was firstly to observe whether estrogen deficiency would 
affect the implant healing in the posterior maxilla area as well as whether  the commercial 
modified rough surface implant can overcome the negative influence of osteoporosis. 
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1.3 Thesis outline 
1    Introduction of thesis 
2    Hypothesis & Aims: Based on the total hypothesis and aims of this project, which was 
further divided into four small projects. Following is a brief overview of the contents 
about the project. 
3   Literature Review: The literature review is divided into two parts.  
o     The first part was about the bone environment and the compromised factors on 
osseointegraton.  
o     The second part reviewed the possible relationship between the osteocyte and 
dental implant. 
(Manuscript in preparation: “The emerging roles of osteocytes in osseointegration”) 
4   First experimental chapter: The rat maxilla model of osteoporosis. This chapter 
answered the question about whether estrogen deficiency would affect the rat maxilla.  
(Paper accepted:  “Estrogen Deficiency-Associated Bone Loss in the Maxilla: A 
Methodology to Quantify the Changes in the Maxillary Intra-radicular Alveolar Bone 
in an Ovariectomized Rat Osteoporosis Model”). 
5   Second experimental chapter: The second part assessed the suitability and feasibility of 
placing dental implants into the rat maxilla and to establish parameters to be used for 
dental implant research using this model.  
(Paper accepted:  "Evaluation of the 1st maxillary molar post-extraction socket as a 
model for dental implant osseointegration research”). 
6   Third experimental chapter: to visualize the ultrastructural of osseointegraton in vivo 
and explore the possible role for osteocytes and their lacunar–canalicular network in 
osseointegration. 
(Paper accepted:  "The Ultrastructural Relationship Between Osteocytes and Dental 
Implants Following Osseointegration."). 
7   Fourth experimental chapter: This chapter addressed the questions of whether estrogen 
deficiency would affect the implant healing in the posterior maxilla area as well as 
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whether a modified rough surface implant could overcome the negative influence of 
osteoporosis. 
 (Manuscript in preparation: “The effects of osteoporosis and implant topography on 
osseointegration in rat maxilla.”). 
8    Concluding Remarks: Summary of key findings and conclusions of the project. 
 
Ethics approvals for the PhD project 
Part of samples (the first and third part of the research) come form China, research 
protocols were approved by the Animal Care and Use Committee of Fujian Medical 
University (181/2009). 
The other experimental protocols was proved by The Griffith University Animal Ethics 
Committee (DOH/01/4/AEC). 
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2.1  Hypothesis         
 Osteoporosis is one of the widespread bone disorders characterized by decreased bone 
mineral density and a deterioration of bone microarchitecture and deserves further discussion. 
Titanium dental implants have been established as a predictable treatment modality for tooth 
replacment, and micro-rough surfaced implants have been used to improve osseointegration. 
However, the extent to which osseointegraton is affected by osteoporosis is yet to be fully 
elucidated, and it is yet to be determined whether micro-scale modified implants can 
overcome the negative influence of osteoporosis.  The hypotheses of this project were: 1) 
Estrogen deficiency induced by ovariectomy leads to reduced bone density in the rat maxilla; 
2) Eastrogen deficiency would impair the osseointegration process of dental implants placed 
in the dental maxilla;. 3) Moderately rough surfaced implant can improve osseointegration in 
this compromised bone environment; 4) Osteocyte play an important role in the process of 
osseointegration . 
 
2.2  AIMS OF THE PROJECT 
AIM 1: To verify that the rat maxilla undergoes changes following overectomy induced 
estrogen deficiency, and hence represents an appropriate model for osteoporosis research  
            . 
AIM 2: To verify that the rat maxilla is an appropriate  model for dental implant 
osseointegration research.  
AIM 3: To observe the ultrastructural aspects of bone-implant interface following 
osseointegraton, especially the relationship of 
             osteocytes with the dental implant. 
AIM 4:  To observe the effects implant surface topography ofon implant osseointegration 
in the rat maxilla  under estrogen deficiency induced osteoporotic-like conditions.. 
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  The study was divided into four parts. 
  Part 1  Rat maxilla osteoporosis model study 
  The effects of estrogen deficiency on bone characteristics are site-dependent, with the 
most commonly studied sites being appendicular long bones (proximal femur and tibia) and 
axial bones (vertebra). The effect on the maxillary and mandibular bones is still inconsistent 
and requires further investigation. This study was designed to evaluate bone quality in the 
posterior maxilla of ovariectomized rats. The design as follows: 
  Rats were randomly divided into two groups: an ovariectomized group (OVX, n=24) 
and Sham-operated group (SHAM, n=24). Six rats were randomly sacrificed from both 
groups at time points 8, 12, 16 and 20 weeks. The samples from tibia and maxilla were 
collected for Micro CT and histological analysis.  
  The volume of interest (VOI) region focused on the furcation areas of the first molar 
and second molars of maxilla. Initially, a circle with 40 pixel (0.64 mm) diameter was 
selected at the most coronal aspect of the root furcation, and after a further 40 slices apically 
a circle was selected with 60 pixel (0.96 mm) diameter. A third circle with the same diameter 
was then selected after another 60 slices and eventually, the VOI was defined by morphing 
across the slices between these three circles, forming an irregular, conical cylinder. 
  Trabecular bone volume fraction (BV/TV, %), trabecular thicknesses (Tb.Th.), 
trabecular number (Tb.N.), trabecular separation (Tb.Sp.), and connectivity density 
(Conn.Dens) were determined for VOI using the micro CT evaluation software SCANCO 
(Scanco Medical AG, Bassersdorf, Switzerland) provided with the micro-CT system. 
Part 2  Rat maxilla implant model study 
Published information regarding the use of rat jawbones for dental implant 
osseointegration research is limited and often inconsistent. This study assessed the suitability 
and feasibility of placing dental implants into the rat maxilla and to establish parameters to be 
used for dental implant research using this model. The design as follows: 
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 Titanium implants (2×3mm) were placed bilaterally in the maxillary first molar area of 
21 Sprague-Dawley rats. The animals were subsequently sacrificed at days 3, 7, 14, 28 and 
56 post-surgery. Samples were prepared for histological and histomorphometric analyses. 
  Histomorphometric analysis of each specimen was then determined using ImageScope 
software (Aperio Technologies Inc). The percentage bone implant contact (%BIC) and the 
bone area (BA) were  measured and analyzed.   
  Part 3  The ultrastructural of osteocytes with implants          
  Osteocytes influence bone remodeling by controlling the differentiation and activity of 
osteoblasts and osteoclasts. Determining the relationship(s) between titanium implants and 
osteocytes may therefore benefit our understanding of the process of osseointegration. The 
study was designed to observe the ultrastucture relationship of osteocytes with implant. The 
design as follows: 
  Titanium implants were placed in the maxillary molar region of eight female Sprague 
Dawley rats. The animals were sacrificed 8 weeks after implantation and undecalcified tissue 
sections were prepared. Resin-cast samples were subsequently acid-etched with 37% 
phosphoric acid prior to examination using scanning electron microscopy (SEM). 
  The sections were coated with gold and examined using a Carl Zeiss SIGMA VP field 
emission scanning microscope (FE-SEM; Carl Zeiss. SMT GmBH, Oberkochen, Germany) 
operated at a voltage of 15 or 20 kV. The focus of the ultrastructural analysis was the 
interface between bone and the implant surface. Elemental analysis was performed using the 
polished samples coated with gold with the same scanning microscope. 
  The morphology of osteocytes nearly implants were observed and analyzed. 
Part 4  The effects of osteoporosis and implant topography on osseointegration in 
the rat maxilla.  
  Whether osteoporosis would affect ossseointegration is still a controversial issue. 
Furthermore, researchers rarely use osteoporotic animal maxilla models as a research object 
to evaluate whether it is a risk factor for dental implant healing. Empirical study proves rough 
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surfaced titanium implants would result in superior bone to implant contact compared to 
traditional machined (namely smooth surface) implants. Whether the rough surfaced implant 
could reduce the osteoporotic influence on the implant healing process deserve study. The 
relationship of estrogen deficiency — osseointegration is still not clear. This study was 
designed to observe the effects of osteoporosis and implant morphology on osseointegration 
in rat’s maxilla, while the possible role of osteocytes will also be investigated.  The design as 
follows: 
  Moderate rough surface implant and smooth surface implant were immediately 
implanted into the first molar mesial root socket separately after tooth extraction from the 
maxilla of both ovariectomy (OVX) and sham-operated (SHAM) rats.  The rats were 
sacrificed at 3, 7, 14, 28 days separately for the observation.  
  Bone healing process and osseintegraiton were evaluated through histological 
observation, cryo-fracture plug SEM observation, and real-time PCR. 
  The expression of targeted genes, including alkaline phosphatase (ALP), osteocalcin 
(OC), alpha-1 type I collagen(COL1A), Receptor activator of nuclear factor kappa-B ligand 
(RANKL), Tartrate-resistant acid phosphatase (TRAP), Dentin matrix protein 1 (DMP1), 
sclerostin (SOST), Tumor necrosis factor-alpha (TNFα) and interleukin-1β (IL-1β) were 
analysed. 
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3.1  Review 1 
3.1.1 The biology of bone tissue 
Bone is the main constituent of the skeletal system, which primarily functions as the 
supporting framework of the human body. Aside from this  structural function, it also serves 
many other purposes such as protecting the various organs of the body, assisting mobility, 
formation of hematopoietic cells and storage of minerals (especially calcium and phosphate). 
The total number of bones in the human body is 206, and they are categorized into 
different types based on their organization: the axial skeleton and appendicular skeleton. 
From an anatomical perspective, bone also can be defined as: flat bones (skull bones, 
mandible, scapula and ilium) and the long bones (limb bones – humerus, ulna, radius, femur, 
tibia, fibula etc.). Bone is composed mainly of mineralized osseous tissue. Besides its cellular 
components (i.e. the osteoblasts and osteocytes), the bone tissue includes marrow, endosteum 
and periosteum, nerves, blood vessels and cartilage. The origin of bone formation during the 
fetal stage of development occurs by two processes: intramembranous ossification and 
endochondral ossification. Intramembranous ossification is responsible for formation of most 
of the flat bones of the skull but also the mandible, maxilla, and clavicles, and osteogenesis 
occurs directly and without any intermediate cartilage. The steps mainly include: 
development of an ossification centre, calcification, formation of trabeculae and development 
of periosteum. However, in endochondral ossification, (typically involved in the formation of 
the axial and appendicular skeletons), osteogenesis occurs directly from mesenchymal cells 
initially condensing to form a cartilage intermediate, which is eventually replaced by 
mineralized tissue. The steps may be summarized as follows: Development of cartilage 
element, growth of cartilage element, development of the primary ossification center, 
development of the secondary ossification center, formation of articular cartilage and 
epiphyseal plate. 
Bone tissue classification is based on histological appearance as either compact (cortical 
bone) or spongy (trabecular/spongy bone). Cortical bone is important for providing the 
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supporting structure and surrounds the trabecular bone. Spongy bone on the other hand, 
contains inter-connected bony trabeculae. Based on the mineral arrangement, bone also can 
be divided into lamellar bone and woven bone. Lamellar bone characteristically has well-
structured morphology, consisting of concentrically (in compact bones) or parallel (in spongy 
bones) organized lamellae of collagen fibers. In compact bones, the concentrically arranged 
lamellae surround a central channel that contains blood vessels and nerve fibers (Haversian 
canal). Another system of canals (Volkmann’s canals) run perpendicular to the Haversian 
system and provide inter-connection between the inner and outer layers of bone.  Woven 
bone is immature and does not have any orderly arrangement of collagen fibers as is the case 
with lamellar bones. Such bone is formed in regions requiring rapid bone formation, for 
example, fracture healing.  
Bone tissue consists of a mineral phase intimately embedded into an organic matrix[1]. 
The mainly inorganic phase of bone is hydroxyapatite, a calcium phosphate apatite. The Ca/P 
ratio of bone tissue varies from 1.50 to 1.90, depending on age and the bone site. However 
the ideal atomic ratio of Ca/P is 1.67, but this may be affected by aging or bone disease[2].   
 
3.1.2 Bone cells 
There are three different types of cells – osteoblasts, osteocytes and osteoclasts existing 
as the essential living components of bone tissue. Osteoblasts originate from mesenchymal 
stem cells and are located on the surface of osteoid seams. They make a protein matrix 
known as osteoid that is mineralized to form bone. Some of the terminally differentiated 
osteoblast cells eventually get trapped in the lacunae of the matrix and form osteocytes. 
Osteocytes embedded in bone tissue are the most abundant cell population, comprising ~90-
95% of all bone cells in adult bone and are the longest lived bone cell [3]. The osteocytes are 
distributed throughout the bone matrix and are interconnected to one another, as well as cells 
on the surface and the bone marrow through their extensive dendritic network. They form an 
extended, three-dimensional (3D) network, with processes interconnecting the cell bodies 
residing in thin canals, known as canaliculi. Together with the osteocyte lacunae, the 
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canaliculi form the lacuno-canalicular network (LCN) [4]. (Fig.1) They have recently been 
found to function as an orchestrator, regulating both osteoclast and osteoblast activity and 
mineral metabolism[5]. The third type of bone cell is the osteoclast, and osteoclasts comprise 
1-2% of bone cells. They are formed by the fusion of mononuclear cells of the 
monocyte/macrophage lineage. Osteoclasts are polarized multi-nucleated cells which are 
responsible for bone resorption in the bone remodelling process. It is believed that the 
monocyte/macrophage colony–stimulating factor (M-CSF) and the receptor activator of 
nuclear factor κB (NF-κB) ligand (RANKL) are the essential factors for differentiation of 
osteoclasts [6, 7]. The interplay between osteoblasts and osteoclasts is responsible for 
maintaining normal bone homeostasis in the human body. Osteocytes modulate the activity of 
both of these types of cell. Mature osteocytes are viable for about 10 years, osteoblasts for 
about 9 months and osteoclasts for about 3 weeks[8]. 
 
 
 
 
 
 
 
 
 
                                                  Fig.1   An osteocyte and its LCN structure. 
 
As the most important cell in creating and maintaining skeletal architecture, osteoblasts 
are derived through the differentiation of osteogenic cells in the periosteum (tissue that 
covers the outer surface of bone), and in the endosteum of the marrow cavity (usually located 
in the deeper layers of the periosteum and bone marrow). Osteoblasts are the principal cells 
in the bone forming process.  During the process of osteoblast differention, osteoprogenitor 
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cells have the ability to express Runx2/Cbfa1 transcription factor,  which regulates the 
expression of several osteoblastic genes, such as COL1A1, alkaline phosphatase (ALP), bone 
sialoprotein (IBSP), SPP1 (osteopontin) and BGLAP (osteocalcin)[9]. Other osteogenic 
markers that are expressed during differentiation include Osterix, M-CSF, osteocalcin (OC) 
and osteonectin (ON).  Once the bone has formed, most of the mature osteoblasts undergo 
apoptosis, while a few of them transform into the bone lining cells known as osteocytes. 
(Fig.2, 3)  
 
 
 
 
 
 
 
 
                    Fig.2 Expression of markers during osteoblast-to-osteocyte ontogeny[5] 
 
 
 
 
 
 
 
 
 
Fig.3 Origin of osteoblasts in humans. The osteoblast precursors proliferate and give rise to osteoblasts 
which in turn lay the bone matrix and also give rise to the osteocytes [10] 
 
Morphologically, mature osteoblasts are cuboidal in shape, with their size varying 
between 20-30µm in diameter[11]. Osteoblasts become flattened and elongated upon 
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maturation. These cells have cytoplasmic projections that allow them to form 
communications with adjacent osteoblasts and osteocytes. When they are active, a large 
Golgi apparatus and an abundant rough endoplasmic reticulum is visible[12]. Osteoblasts 
usually form a single layer of cells on the surface of bone. However in cases where there is 
active bone formation, they may be present in the form of layers[11]. 
The principal function of osteoblasts is bone formation. As mentioned earlier, these cells 
are responsible for the deposition of bone matrix and for osteoclast regulation, and when they 
differentiate they obtain the ability to secrete bone matrix [13]. They are also responsible for 
the synthesis of various kinds of proteins and polysaccharides. These cells also play an 
important role in bone remodelling by maintaining a balance between bone formation and 
resorption during new bone formation. Rarely, osteoblasts are also known to initiate the bone 
resorption process. Mature osteoblasts synthesize several phenotypic markers like, type I 
collagen, alkaline phosphatase (ALP) and osteocalcin (OC).  
 
3.1.3 Bone remodelling cycle and the key role of osteocytes 
The bone remodelling process can be defined as the removal of mineralized bone by 
osteoclasts, followed by the formation of a bone matrix by osteoblasts that subsequently 
become mineralized. The continual process of adult bone remodelling is important for the 
maintenance of bone mass and skeletal microarchitecture [14]. Osteocytes, osteoclasts and 
osteoblasts are the basic multi-cellular unit of bone remodelling (BMU) which  is  covered  
by  a  ‘canopy’  of  cells  (most probably  bone-lining  cells)  that  together form  the  bone  
remodelling compartment  (BRC) [15] (Fig.4).  There is increasing evidence that osteocytes 
play an important role in the cycle of targeted bone remodelling.  In this context, it is 
noteworthy that the entire bone surface is not constantly undergoing active remodelling.  
Indeed, over 95% of the surface of the bone tissue is inactive because of osteocytes exerting a 
quiescent inhibition of both osteoclastic bone resorption and osteoblastic bone formation [16]. 
By contrast, once local skeletal microdamage occurs or the mechanical loading decreases, 
osteocytes react either by secreting cytokines and chemoattractants or by undergoing 
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apoptosis. These reactions trigger local recruitment of osteoclast precursor cells and mature 
osteoclasts to initiate bone resorption [14]. Osteoclast resorption activity lasts over a period 
of 3–5 weeks until this process is terminated by apoptosis and followed by recruitment of 
osteoblast precursors. Subsequently, in the next 3 months osteoblasts secrete and mineralize 
osteoid to replace the resorbed bone [16]. The whole process is regulated by osteocytes, 
which alter the rate of bone remodelling by controlling osteoclast formation via the 
production of RANKL. On the other hand, osteocytes also control the balance between 
formation and resorption by regulating osteoblast formation via production of sclerostin, 
which is encoded by the SOST gene and highly expressed in mature osteocytes. Its primary 
function is to impede bone formation.  Sclerostin may have additional functions, such as 
stimulation of RANKL expression by osteocytes [15, 17]. The balance between osteoclast 
and osteoblast activity results in skeletal homeostasis with preservation of bone strength[18]. 
In brief, the bone remodelling cycle is initiated and orchestrated by osteocytes, and 
propagated through coupled cross-talk between osteoblasts and osteoclasts. 
 
 
 
 
 
 
 
 
 
Fig.4 The bone remodelling compartment (BRC) comprises the cells constituting the basic multi-cellular 
unit (BMU)[15] 
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3.1.4 Disorders of bone homeostasis 
One of the important functions of bone is the housing and support of hematopoiesis, any 
reason causes the bone homeostasis may possibly damage its function. The above described 
bone remodelling process is a cycle of resorption, carried out by osteoclasts, and formation 
by osteoblasts. In the adult skeleton, an appropriate balance between the processes of bone 
formation and resorption is necessary for maintenance of appropriate bone homeostasis. The 
balance between bone formation and resorption is also vital to avoid microdamage 
accumulation and to preserve the proper material and structural integrity of the bone. This 
balance may be disrupted in certain situations leading to clinical conditions causing 
significant morbidity. While individual conditions may have a genetic and/or developmental 
etiology (e.g. osteogenesis imperfecta); others are associated with the cumulative effects of 
predisposing factors (e.g. osteoporosis). Some of the common disorders of bone homeostasis 
are osteoporosis, rickets and osteomalacia, Paget’s disease of bone, renal osteodystrophy and 
osteogenesis imperfecta. Osteoporosis is a widespread bone disorder characterised by 
decreased bone mineral density and a deterioration of bone microarchitecture. Therefore, the 
issue of whether osseointegraton would be affected by osteoporosis is clinically relevant and 
warrants ongoing investigation. 
 
3.1.5 Osseointegration  
When an implant is placed into bone tissue, the healing process is very important for 
future implant success. Although many studies have tried to investigate the mechanisms of 
osseointegration, the regulatory factors of bone formation around implants are still not fully 
understood. Bone healing around implants is considered similar to the fracture bone healing 
process wherein blood is invariably the first tissue that the implant will contact. This contact 
results in the activation of a cascade of biological processes in the gap between the implant 
and the bone tissue, such as protein deposition, coagulation, inflammation, and tissue 
formation[19]. Animal studies have revealed that when implants are put into the bone cavity, 
the gap between the implant and bone tissue is immediately and rapidly filled with blood clot, 
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red blood cells, inflammatory cells mainly consisting of neutrophils, and degenerating 
cellular elements[20, 21]. After 3-5 days, a layer of flattened cells with interposed blood 
capillaries lines the implant surface and the intercellular spaces are filled with fibrin. In 5–7 
days after implantation, the newly formed bone tissue/osteoid mixed with cuboidal cells can 
be observed on the implant surface [22].  Meyer et al reported that just 3 days after 
implantation some small bone-like crystals can be observed at the implant surface [23]. At 28 
days after placement, the implant appears well osseointegrated [22, 24]. Newly formed bone 
can be seen around the implant surface forming a reticular structure with wide marrow spaces 
at trabecular areas [24]. A primary spongiosa, rich in vascular structures is also reported [21]. 
Although many researchers have histologically described the process of osseointegration, the 
cellular and molecular events in the early bone formation around implants have not been 
clarified. Different cell types, growth factors and cytokines are all involved in a co-ordinated 
manner during the inflammatory, formation and remodelling phases of bone healing. This 
means that osseointegration should be regarded not as an exclusive reaction to a specific 
implant material, but as an endogenous bone regenerative process [25]. 
Until now, knowledge of "osseointegration" of titanium implants is mainly based on 
clinical experience and light microscopic observations (LM) [26].  In order to promote 
osseointegration around bone tissue, researchers need to know the exact response at the 
interface, which includes the material and host response. As we know, the material response 
consists predominantly of oxidation of the metallic implant surface, which undergoes a string 
of electrochemical changes in the physiological environment. The material selected for 
implants must have a stable oxide film, and for the commercially pure Ti implants routinely 
used in dental implantology, the thickness is 2-6nm before implantation [27].  The design, 
chemical composition and topography of the implant surface can also influence peri-implant 
tissue healing [28]. Rough surfaces have been shown to promote osseointegration [29, 30].  
After implantation, the host response is the main determinant of the wound healing 
response in the early stages of the osseointegration process. The early response after 
implantation into bone tissue is the adsorption of proteins, which subsequently undergo 
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desorption (native or denatured, intact or fragmented) or remain to mediate the subsequent 
tissue-implant reaction [31, 32], including cell adhesion and binding to the material surface 
[33, 34]. The interaction of red blood cells, fibrin and platelets with the implant surface may 
modulate the migration, differentiation and activity of osteogenic cells during peri-implant 
healing [35, 36]. These events are the early biological processes and osteoblasts have been 
found to attach on the implant surface from day one of implant insertion. [23]. The attached 
osteoblasts start depositing collagen matrix directly on the implant surface, forming a cement 
line/lamina limitans layer, which is an early-formed calcified afibrillar (0.5mm thickness) 
layer containing abundant amounts of calcium, phosphorus, osteopontin and bone 
sialoprotein [37]. However, whether osteoblasts actually interact directly with the implant 
surfaces in vivo is still controversial [38].  
Bone tissue is constantly metabolised throughout life. These metabolic activities are 
executed by bone-resorbing osteoclasts and bone-forming osteoblasts, cells that are recruited 
from the bony environment. Mounting evidence suggests that osteocytes can modulate this 
process [39-41] and play an active role in the bone metabolic process through the lacuno-
canalicular system [5]. Therefore, elucidation of the role of osteocytes in the remodelling of 
the bone surrounding implants will help to understand the dynamic bone metabolic process 
following osseointegration. Since osteocytes are the terminal cells of osteoblasts, 
understanding the relationship of osteocytes with implants also benefit comprehension of 
early bone formation relationship between osteoblasts and implants. 
 
3.1.6 Osseointegration Under Compromised Conditions 
Dental implants manufactured from titanium have become a well-established treatment 
modality for the replacement of missing teeth. The clinical procedures using dental implants 
are well documented, with good long term success rates reported in healthy patients and in 
favourable anatomical positions [42]. However, with increased clinical use, greater 
acceptance and popularity of implants, there are greater demands on implant systems from 
both clinicians and patients. In particular, there is demand for implant placement in sites 
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where the quality of bone is less than ideal, such as those encountered in systemic conditions 
where the amount of mineralised tissue is reduced (osteoporosis) and/or the bone wound 
healing is compromised (uncontrolled diabetes mellitus or the use of  intravenous 
bisphosphonates). 
Due to the increasing clinical demands, there are continuing efforts to enhance the rate 
and amount of osseointegration, especially in compromised scenarios. One of the parameters 
which have been shown to influence the success rate of implants is the alteration of the 
surface topography by increasing the roughness of the implant surface [43]. Indeed, the use 
of microscale modifications of implant surfaces has been credited with being one of the key 
factors in increasing the clinical success rate of implants, especially in areas of compromised 
bone quality [44]. However, the cellular and molecular mechanisms responsible for these 
superior clinical outcomes are poorly understood [43]. Further improvements in implant 
design, surface characteristics and surgical protocol are hampered by a lack of understanding 
of the fundamental biological mechanisms that result in osseointegration, and in particular 
how these mechanisms are influenced by surface modification.  
 
3.1.7 Compromised Clinical Scenarios 
3.1.7.1 Osteoporosis 
Osteoporosis (OP) is a bone-weakening systemic disease. It is estimated that over 200 
million people suffer from this disease and over 40% of postmenopausal women experience a 
fractured bone some time during the rest of their lives[45, 46]. Osteoporosis is a condition 
characterised by decreased bone mineral density and a deterioration of bone 
microarchitecture, and hence compromised bone quality. It is prevalent in females and its 
incidence increases with age. In Australia, it is estimated that 50% of the women and 33.33% 
of men beyond the age of 60 years develop fractures due to osteoporosis [47]. Osteoporosis 
can be divided into primary and secondary types. The primary type also can be sub-divided 
into type I and type II [48].  Our research is mainly focused on the type I that is Post-
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menopausal (type I) osteoporosis, which is a common bone disorder in postmenopausal 
women and is caused primarily by estrogen deficiency resulting from menopause. This form 
of osteoporosis is exemplified by accelerated bone loss. The skeletal loss occurs primarily 
from trabecular bone, leading to distal forearm and vertebral body fractures. Type II is senile 
osteoporosis, and mainly occurs in both men and women over the age of 70 years and is due 
to the loss of cortical and trabecular bone. Fractures of the wrist, spine and hip are often seen 
with type II osteoporosis. Secondary causes of osteoporosis are due to disorders classified as 
genetic (congenital), endocrine, hypogonadal states, deficiency states, drug-induced, 
inflammatory states, hematologic, neoplastic and miscellaneous. (Fig.5) 
 
 
 
 
 
 
                Fig. 5. Scanning electron micrograph of normal bone (left) and osteoporotic bone(right). [49] 
 
Estrogen deficiency is thought to be the critical in the pathogenesis of post-menopausal 
osteoporosis. In the post-menopausal period, due to estrogen deficiency, bone structure is 
reduced and changed. The studies have proved that both bone resorption and bone formation 
are increased in postmenopausal osteoporosis; however, the extent of increased bone 
resorption exceeds that of augmented bone formation, which causes an imbalance between 
bone resorption and bone formation in favour of bone resorption[50]. The understanding of 
the molecular and cellular mechanisms underlying the role of estrogen deficiency in the 
pathogenesis of postmenopausal osteoporosis was studied mainly in the 1980s and 1990s. In 
1980s, research focused on the cytokines including interleukin (IL)-1, −6, and −7; tumour 
necrosis factor (TNF); granulocyte/macrophage colony–stimulating factor (M-CSF). The 
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breakthrough discovery was made in the 1990s, through the understanding of 
RANK/RANKL and OPG roles in osteoclastogenesis[50]. (Fig.6)  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6 Current understanding of the pathological mechanisms of postmenopausal osteoporosis. Dates 
indicate the time of the discovery of the functions. Abbreviations: FSH, follicle-stimulating hormone; IL, 
interleukin; M-CSF, monocyte/macrophage colony–stimulating factor; OPG, osteoprotegerin; RANK, 
receptor activator of nuclear factor κB; RANKL, RANK ligand; TNF, tumor necrosis factor[50]. 
 
Estrogen can directly and/or indirectly have effects on osteoclast, osteoblast and 
osteocytes.   
It is now firmly established that osteoblasts, osteocytes, and osteoclasts express 
functional estrogen receptors (ERs) [51]. Recent studies have clearly demonstrated that 
estrogen can induce osteoclast apoptosis, through osteoclast-specific deletion of ERa (using 
Cre driven from cathepsin-K or lysM, respectively), can reduce osteoclast apoptosis and 
relatively increase osteoclast lifespan which results in decreased trabecular bone mass[15, 52]. 
Estrogen also can induce ERa binding to a  scaffolding protein, Breast cancer anti-estrogen 
resistance protein 1 (BCAR1); the ERa/BCAR1 complex then isolates TNF receptor-
associated factor 6 (TRAF6), inhibiting RANKL-stimulated osteoclastic differentiation  of  
human  monocytes and leading  to  decreased  activation  of  NF-кB  and impaired  RANKL-
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induced  osteoclastogenesis [53]. Estrogen also can inhibit RANKL-induced 
osteoclastogenesis through reduction of c-Jun activity (estrogen reduces c-Jun expression and 
decreases phosphorylation) to block RANKL/M-CSF-induced activator protein-1-dependent 
transcription. Estrogen can also indirectly regulate  osteoclast formation through  suppressing  
RANKL  production  by  osteoblasts,  T  and  B  cells [54]  and  also  increasing production  
of  the  decoy  receptor  for  RANKL,  osteoprotegerin  (OPG)  [15, 55].  Estrogen can direct 
effects on osteoblasts through three pathways: inhibiting apoptosis, suppressing oxidative 
stress, and decreasing NF-kB activity.  The effects of estrogen on reducing osteoblast 
apoptosis are due to activation of the Src/Shc/ERK signalling pathway. Aging and estrogen 
deficiency may lead to impairment in bone formation involving oxidative stress. Estrogen 
deficiency also can lead to a marked increase in NF-kB activity in osteoblast cells. Using 
estrogen treatment, osteoporosis patients would induce the potent inhibitor of bone formation, 
sclerostin[56].  As sclerostin is expressed by osteocytes, this in turn means estrogen also 
affects osteocytes. (Fig.7) 
 
 
 
 
 
 
 
 
 
 
       
 Fig.7 Working model for estrogen regulation of bone turnover via effects on osteocytes, osteoblasts, 
osteoclasts, and T cells [15] . 
 
The effects of estrogen  on jaw bone compared with long bone has been a controversial 
issue until now[57]. The reasonable explanations for the inconsistent reactions of jaw bone 
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compared with long bone were always attributed to the differences of ossification patterns 
and embryological origins.  Jaw bone is both morphologically and functionally different from 
the other bones of the axial or peripheral skeleton. It also derives from a different embryonic 
origin (neuroectoderm) compared with bone of the axial and appendicular skeleton, which 
arises from mesoderm[58], and the intramembranous ossification of jaw bone differentiates 
with the endochondral ossification of long bone. From recent research, it appears that the 
differences of long bone and jaw bone reaction to estrogen deficiency are based on inherent 
genetic differences between the bone of cranial origin and the bone of non-cranial origin[59].  
This seems to explain the behaviour differences of osteoblasts between jaw bone and long 
bone[60]. Following the development of dental science, especially as dental implants become 
a mainstream restoration for the edentulous patients, dentists are more careful about the 
effects of systematic disease on jaw bone. It has been hypothesised that osteoporosis affects 
the jaws in the same manner as other bones of the skeleton, and thus may also alter bone 
metabolic microenvironments around the implant. Since it is well recognised that dental 
implants, especially those with a machined surface, perform worse in areas of poor bone 
quality such as the posterior maxilla, osteoporosis can be considered a good model for the 
study of osseointegration in poor quality bone. Furthermore, osteoporosis itself has been 
shown to be a risk factor for implant failure [61], although it is unclear if this negative effect 
is overcome by the use of implants with a micro-rough surface topography [62]. Determining 
the precise extent to which surface modification can influence healing in a poor quality bone 
environment through the use of an osteoporotic model has important clinical implications, 
especially given the extensive incidence of osteoporosis in the general population.  
Of all the animal models of osteoporosis, the ovariectomized rat has been selected as the 
preferred model to simulate human post-menopausal osteoporosis. This is because both share 
many similar characteristics, including an increasment of bone turnover rate which represent 
by the resorption exceeding formation, an initial rapid phase of bone loss followed by a much 
slower phase; greater loss of cancellous bone than cortical bone; and similar skeletal response 
to therapy with medicines [63]. Other important reasons are ease of handling and housing, 
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[64]. However, because the jaw bone is small and difficult to operate on, the potential for 
using jaw bone as a research object for implants is limited, especially the maxilla. 
Additionally, the potential for using a rat’s maxilla is limited compared to the mandible. The 
reason presumably being that the anatomy of maxilla is more complicated compared to the 
lower jaw.  
In brief, whether the jaw bone is affected by osteoporosis is still a controversial issue, the 
prerequisite condition for using the rat maxilla as an osteoporosis model to observe the bone-
implant healing process, is to first identify whether this site has become osteoporotic.    
 
 3.1.7.2 Microscale titanium surface modification and osseointegration  
The design, chemical composition and topography of the implant surface can influence 
peri-implant tissue healing [28]. Commercially pure titanium (Ti) is widely used as a dental 
and orthopaedic metallic implant material. It is a highly biocompatible material with good 
resistance to corrosion, no toxicity on macrophages or fibroblasts, and lack of inflammatory 
response in peri-implant tissues. However, smooth or machined implant surfaces have been 
replaced by topographically modified microroughened implants in recent years. Animal 
studies have shown that micro-rough titanium implants result in superior bone to implant 
contact compared to machined (minimally rough) implants [65, 66], as well as having 
superior torque removal values [67, 68]. Histological analysis of the sequential healing events 
associated with the placement of micro-rough surface titanium implants shows that initial 
bone formation around these implants occurs not only at the exposed bone wall of the 
surgically created implant recipient site, as is the case with machined surface implants, but 
also along an “osteophilic” implant surface [21]. The study also demonstrated histological 
evidence of superior early healing is associated with the micro-rough surfaces, which shows a 
higher level of organization in the wound observed as early as 4 days following implantation, 
ultimately leading to greater bone-implant contact one week post-insertion. These findings 
suggest that key biological events leading to the superior histomorphometric characteristics 
and clinical performance of modified implant surfaces occur early in the wound healing 
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process at the tissue-implant interface. Thus, during osseointegration, implant surface 
topography appears to influence cellular and molecular mechanisms at the tissue-implant 
interface.  
Given that implant therapy has a very high success rate in healthy patients with good 
bone quality and quantity, one of the major foci of current research is the performance of 
implants in compromised sites and patients. Therefore, understanding the extent to which 
microscale modified implants can overcome the negative influence of systemic bone 
conditions has a clear clinical relevance.  
3.1.7.3 Biological mechanisms  
Osseointegration is a complex process that involves a cascade of events that occur at the 
tissue-implant interface. These involve clot formation and the initial adsorption of serum 
components immediately following implant placement, an immune-inflammatory response to 
implant insertion, the migration and attachment of undifferentiated mesenchymal cells on the 
implant surface, their proliferation and differentiation, and finally, the formation of 
extracellular matrix and its mineralization and maturation. However, little is known about the 
mechanisms which are affected by systemic disease and how they may be modulated by 
surface modification. Recent studies have shown that using a human in vivo model 
inflammation, the main biological processes that are involved in osseointegration are 
skeletogenesis, angiogenesis and neurogenesis. [69, 70]. Concurrently, IkB/ NFkB, Wnt and 
TGfb/BMP signalling is prominently regulated during the osseointegration process. Although 
the biological processes of osseointegraton are now beginning to be elucidated, little is 
known about the mechanisms via which systemic disease can influence osseointegration, or 
how titanium surface micro-roughness can modulate this effect. 
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3.2  Review 2  The emerging roles of osteocytes in osseointegration 
 
Zhibin Du, Nishant Chakravorty, Saso Ivanovski, Yin Xiao 
(Manuscript prepared for Clinical Oral Implants Research)
 
3.2.1 Abstract 
 The recent revelation that osteocytes play a crucial role in the maintenance of bone 
homeostasis has challenged the conventional view that they are passive placeholder cells. As 
mechanosensors, osteocytes sense mechanical strain and are known to orchestrate the 
activities of osteoblasts and osteoclasts and are therefore seen to play several key regulatory 
roles in bone modelling and remodelling process. Osseointegration is a dynamic process that 
is thought to include all the activities similar to bone remodelling process as it occurs in the 
natural bone environment. This review seeks to reconcile the gap between the existing 
knowledge of osteocytes and osseointegration, explore possible mechanisms of 
osseointegration, and highlight the important role of osteocytes in the osseointegration 
process, a role which is worthy of further investigation.  
 
Key words:  Osteocyte, Osseointegration, Implant, Bone, Remodel  
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3.3.2 Background 
  When Brånemark, the "father” of modern dental implantology, introduced the concept 
of osseointegration, it heralded a revolution in the field of dental implantology and 
established metallic implants as one of the mainstream rehabilitation modalities for dental 
reconstruction procedures [71, 72]. Conventionally, osseointegration has been considered as 
the favourable outcome of the bone tissue healing process around an implant surface and as 
such is considered to be the key biological process responsible for long term implant stability. 
Researchers are constantly trying to improve implant materials in order to achieve a superior 
osseointegration. Although there are a number of studies that have tried to unravel the 
mechanisms of osseointegration, the factors regulating bone formation around implants are 
still not fully understood.  
Bone healing around dental implants is similar to the fracture healing process in many 
ways. Clotted blood is invariably the first tissue to come in contact with the implant. This 
leads to the activation of a cascade of biological processes in the gap between the implant and 
the bone tissue, such as protein deposition, coagulation, inflammation, and tissue formation 
[19]. A comprehensive temporal course of molecular events following implant placement 
have been demonstrated in animal studies. The gap between the implant and bone tissue is 
immediately seen to be filled with blood clot, red blood cells and inflammatory cells (mainly 
consisting of neutrophils, and degenerating cellular elements) [20, 21]. A layer of flattened 
cells and some interspersed blood capillaries can be seen to line the implant surfaces after 3 
to 5 days of implant placement and the intercellular spaces are filled with fibrin (Fig. 1) [73]. 
Newly formed bone tissue/osteoids, mixed with cuboidal cells, is observable on the implant 
surface within 5 to 7 days [22]. Within 28 days, the implant usually appears to be well 
integrated with the surrounding bone [22, 24] and newly formed bone with a reticular 
structure containing wide marrow spaces at trabecular areas is visible around the implant 
surface [24]. Although many studies have described the process of osseointegration from a 
histological perspective, the regulation of cellular and molecular events, especially in the 
early bone formation period around implants has not been well elucidated. 
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Fig. 1 Early stages of the healing process (day 4) on active SLA implant surface shows fibrin 
network filled the bone and implant space with many cell types including red blood cells, platelets and 
white blood cells.  
The process of bone healing around implants, involves coordinated interactions 
between different cell types, growth factors and cytokines that modulate the inflammatory, 
bone formation and remodelling phases. Osseointegraion involves osteogenic differentiation 
of mesechymally derived stem cells, which are  transformed into cells of the osteogenic 
lineage: preosteoblasts，osteoblasts and osteocytes, and the coupled activities of osteoclasts 
and osteoblasts. This process, ultimately leads to the formation of the hierarchical 
mineralised bone tissue around the implant, maintaining its long-term “survival” in the oral 
cavity.  
Research into osseointegration has tended to focus on the “pre” and “pro” osteogenic 
mechanisms such as the role of blood clot and its components or the activation of pro-
osteogenic osteoblastic cellular mechanisms on implant surfaces. However, the influence of 
the predominant bone cell type–the osteocyte–has often been overlooked. Osteocytes have 
recently been found to play a leading role in the bone metabolic process– regulating the 
activities of both osteoblasts and osteoclasts. It is, therefore, plausible that osteocytes play a 
key role in the process osseointegration, something future research should be able to uncover 
[74].  
In a recent study, we examined the morphological differences between tissue samples 
from well-osseointegrated (successful) and non-osseointegrated (unsuccessful) implants in rat 
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animal. Contrary to our expectation, majority of the unsuccessful samples showed no obvious 
signs of inflammation or bone resorption, nor were there any observable changes in the bone 
wall of the implant bed. There was, however, significant difference in osteocytes morphology 
at the implant-bed interface (“interface osteocytes”) between unsuccessful and successful 
implants. In the unsuccessful cases, the interface osteocytes had shrunken cell bodies and 
fewer dendrites, and many were dead.  By contrast,  in successful cases the interface-
osteocytes were seen to have a normal phenotype in the form of an oval shaped cell body and 
many dendrites extending from the cell body (Fig. 2) [75]. These results are similar to a study 
in which bone formation was reduced following the targeted ablation of osteocytes using 
diphtheria toxin [76]. Results such as these support the hypothesis that osteocytes play an 
important role in orchestrating the process of osseointegration. In this review we attempt to 
interpret the existing literature on the functions of osteocytes in order to draw a picture of the 
regulatory role of osteocytes during osseointegration. 
 
 
 
 
 
 
 
 
Fig. 2: Comparison of a successful vs failed dental implant. The successful implant (A and B) shows 
close contact and normal osteocytes on the implant surface; whereas the failed implant (C and D) shows a 
absence of osseointegration and osteocyte with changed morphology and the loss of dendrites (red 
arrows). 
Bone is a complex and highly dynamic tissue organized in a hierarchical pattern 
containing both organic and inorganic components. The organic component consists of 
proteins, mainly type I collagen fibres, and bone cells. The inorganic component 
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predominantly consists of hydroxyapatite crystals. There are three major types of bone cells: 
osteoblasts, osteoclasts and osteocytes being the living components of bone tissue.  
3.2.3 Relationship of osteoblasts with implant 
Osteoblasts originate from mesenchymal stem cells, transforming through a 
preosteoblastic phase, and secreting mineralised bone tissue. There are three destinies for 
osteoblasts: firstly, some of the osteoblasts become apoptotic osteoblasts,  secondly, become 
into bone lining cells, and the third is some osteoblasts get embedded in the mineralised 
matrix and form terminally differentiated osteocytes[77] 
Conventional wisdom holds that osteoblasts play a leading role in the bone healing 
process around implant, which has been investigated extensively both in vitro and in vivo [23, 
78-86]. However, in vivo experiments have yet to conclusively demonstrate if osteoblasts 
actually interact directly with the implants [38]. It is generally thought that mesenchymal 
stromal cells (MSCs) within the bone environment will eventually differentiate into 
osteogenic cells following the placement of an implant. Within the first day of an implantion 
MSCs and osteoblasts-like cells can be found around the implant surface, where they deposit 
bone-related proteins and create an environment conducive for cell adhesion and 
mineraliziation [87, 88]. During the healing process, osteoprogenitor cells express 
RUNX2/Cbfa1 transcription factor that regulates the expression of several osteoblastic genes, 
such as type I collagen (COL1), alkaline phosphatase (ALP), bone sialoprotein (BSP), 
osteopontin (OPN) and osteocalcin (OCN) [9]. Osteoblasts secrete all of these factors; they 
are therefore widely used for analysis of the activities of osteoblasts around dental implants 
[89-92]. The cells attain the ability to secrete bone matrix upon differentiation 
[13]
 and are 
responsible for the synthesis of a number of proteins and polysaccharides. The secreted 
protein matrix, known as the osteoid, entraps some of the mature osteoblasts, which prompts 
their transformation into osteocytes and subsequent mineralization around the implant. 
Recently the view that osteogenic differentiation of MSCs is regulated by osteoblast [93, 94] 
has been challenged by studies that suggest that it is osteocytes that have the lead role in 
regulating the differentiation of MSCs [95-97].  However, the exact molecular mechanisms 
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involved in guiding the transition of osteoblasts to mature osteocytes in this context are still 
elusive [77, 98].  
3.2.4 Relationship of osteoclasts with implant 
  Osteoclasts are cells derived from the hematopoietic lineage, which also give rise to 
monocytes and macrophages [99]. During the bone remodelling osteoclasts are primarily 
implicated in bone resorption. The regulatory role of osteoclasts in osseointegration process 
is not well understood but osteoclasts are known to participate in the bone remodeling 
process around implants as early as day 7 following placement, and have  an important role in 
the long term bone remodeling process [100]. It is believed that moderately rough implant 
surface can not only promote bone healing around implant, but also affect the proliferation 
and differentiation of osteoclasts in vitro [101-103] . Certain factors and  pathways such as 
macrophage-colony stimulating factor (M-CSF), the receptor activator of NF-κB ligand 
(RANKL)-RANK pathway, and osteoprotegerin (OPG), an antagonist of RANKL function 
are known to play an essential roles for osteoclast differentiation and development [104, 105] 
These factors have all been found in and around aseptic loosening of implants [106] or 
associated with bone remodling [107] and peri-implant tissue destruction [108, 109]   
The process of bone remodelling is known to start with bone resorption caused by 
osteoclast; however, the recruitment and subsequent selection for differentiation at the site of 
prospective bone resorption remains unclear. The dynamic remodelling process involves 
osteoclast-guided bone resorption and the coupled osteoblast-guided bone formation. This 
process usually occurs in a basic multicellular units (BMUs) which include osteoclasts, 
osteoblasts, and osteocytes covered by a “canopy” of cells, possible formed by bone-lining 
cells [15]. The lining cells are believed to play a positive role in preparing and conditioning 
the sites of bone resorption [110]. Recently it has been reported that osteocytes play an active 
role in the recruitment of osteoclasts [98]. Osteocytes are to be the major source of RANKL 
during bone remodelling, effectively controlling osteoclasts formation [111, 112], and even 
have the potential to recruit osteoclasts to the sites of remodelling [98]. The osteocyte-like 
cell line MLO-Y4 are reported to express M-CSF, a decoy receptor of RANKL [113], which 
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suggest that osteocytes in the peri-implant healing compartment should be the subject of 
further investigation. 
3.2.5 The emerging role of osteocytes in osseointegration 
Osteocytes embedded in bone tissue are the most abundant cell populations, comprising 
90~95% of all bone cells in adult bone, and are the longest living cells in bone [3]. The 
conventional view is that osteocytes are passive placeholders; however, it is now realized that 
osteocytes have multi-functional roles such as a mechanosensor, and actively regulate bone 
modelling and remodelling process as well as having an endocrine function [74]. Osteocytes 
can sense mechanical strain and the developing microcracks through the loading-induced 
fluid flow which exist in the lacuno-canalicular network (Fig. 3) within the bone, via either 
the  osteocyte body itsself, its dendritic processes or the bending of cilia [114, 115], single 
flagella-like structures found on every cell [116]. Osteocytes also responds to hormonal 
changes (such as estrogen deficiency), by an increase of  osteocytic apoptosis, which triggers 
bone remodelling and resorption [15]. Moreover, osteocytes can regulate of phosphate and 
biomineralization through the expressed molecules such as phosphate-regulating gene with 
homologies to endopeptidases on the X chromosome (PHEX), dentin matrix protein 1 (DMP-
1), and fibroblast growth factor (FGF23) [117, 118]. Other routes through which osteocytes 
can affect bone remodelling is via Dickkopf-related protein 1 (DKK1) and Sclerostin (SOST), 
both of which are antagonists of the Wnt/β-catenin pathway, and highly expressed in 
osteocytes [15]. Therefore, it is now obvious that this “passive placeholder in bone” plays a 
far more important role in bone modelling and remodelling process than what has been 
previously thought. As osseointegration process involves mechanical stimuli (primary 
stability, masticatory force etc), bone modelling and remodelling interaction, the role of 
osteocytes in this process deserve more attention. 
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Fig. 3 Image of the 3D osteocyte lacuno-canalicular network structure. Osteocyte situated in its 
lacunae with its dendrite extend through canaliculi and interconnected with each other which may play 
multifunctional roles.  
3.2.6 The important role of osteocytes in regulating osteoblast activities in 
osseointegration    
     If we appreciate the bone healing process as a result of cell proliferation and 
differentiation, then bone healing around the implant is an ordered process of cell 
differentiation, moving through the stages of pre-osteoblasts, osteoblasts, osteoid osteocytes, 
and mature osteocytes, with interposing osteoclasts activities at the same time. The end 
results is that the osteocyte dendrites make close contact with the implants–the process 
known as osseointegration [119].  Evidence shows that osteocytes are responsible for the 
osteogenic differentiation of MSCs [96]. There are numerous factors involved in this cell-to-
cell process and demonstrating osteoinductive effects [120]. Using avian osteocytes [121] 
and the murine long bone osteocyte Y4 (MLO-Y4) cell line [122], it was shown that 
osteocytes release factors that regulate osteoblast differentiation and ALP activity [74, 121, 
122]. Osteocytes may communicate with osteoblasts through gap junctional intercellular 
communication (GJIC), once they sense the mechanical stimuli, then transmit biophysical 
signals to osteoblasts [123]. Simultaneously they will secrete other factors such as 
prostaglandin E2 (PGE2), ATP, and nitric oxide (NO) (NO also inhibiting osteoclasts activity) 
to closely regulate osteoblasts behaviour 
[74]
. Other secreted factors include insulin-like 
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growth factor 1 (IGF-1) [124, 125], osteopontin (OPN), and parts of bone morphogenetic 
proteins (BMPs) [126, 127] . PGE2 is a multifunctional regulator for bone metabolism and can 
increase the osteocyte gap junction function and plays an important role in the 
osseointegration process [128]. A number of studies also show that PGE2 osteoclastic 
activity [129, 130] and is an important marker associated with peri-implantitis [131, 132]. 
However, osteocytes can also release PGE2 under fluid-flow shear stress and PGE2 actually 
plays a more important role in bone formation than bone absorption [133]. PGE2 seems to 
have the ability to promote osteoblast differentiation [134] and induces bone formation [135] 
through the activates cyclic adenosine monophosphate (cAMP)/protein kinase A signaling 
pathway (cAMP/PKA) [133] and β-catenin signalling pathways [136]. In vitro studies also 
show increased production of PGE2 following osteoblast differentiation on rough surface 
implants [137]. IGF-1 is  a positive regulator of bone formation and osteoblast activity [124, 
125], and has been reported to be strongly expressed by osteocytes in response to under 
mechanical stimuli [138], and using human recombinant IGF-1 subcutaneous infusion can 
significantly inhibits alveolar bone loss following tooth extraction in rats [139]. The 
combination of IGF-1 with either platelet-derived growth factor (PDGF) or transforming 
growth factor beta 1 (TGF-β1) around a titanium dental implant significantly increases de 
novo bone formation within the peri-implant gap [140, 141]. OPN a member of the family of 
Small Integrin-Binding LIgand, N-linked Glycoproteins (SIBLING) [142] is a non-
collagenous bone proteins that is secreted by both osteoblast and osteocytes and recruits 
MSCs to the fracture site and promoting bone formation [35, 143]. An in vitro study has 
shown that OPN is found at considerable levels on the rough surface implant in the early 
healing stages [123]. Bone morphogenetic proteins (BMPs) are another important group of 
growth factors enhancing bone formation and osteocytes secrete BMPs such as BMP-2 [126], 
BMP-3 [127],BMP7 [126] in response to  mechanical stimuli. BMPs play an important role 
in osseointegration process [144-146]. And it was recently shown that BMP-7 was positive 
correlation with SLActive surfaced implant rather than the BMP-2, which significantly 
decreased in SLA surfaced implants [147]. Although there is  no directly evidence of direct 
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osteocyte involvement with the  osseointegration process, Gene array analysis in the early 
osseointegration periods shows the upregulation of soteocyte-related genes such as PHEX, 
DMP-1 DDk1 [148] indicating a complicated molecules crosstalk which is possibly 
controlled by osteocytes.  
3.2.7 The important role of osteocytes in regulating osteoclast activity in 
osseointegration  
Following implant placement, the process of modelling/remodelling of the surrounding 
bone continues throughout the life of the implant, with osteoblasts and osteoclasts working in 
a coordinated manner. Osteoclast activity can be observed around implant surfaces as early as 
7 days following implant placement [100, 149] . Osteocyte apoptosis can occur at the site of 
micro-damage due to the implant placement and this is likely to recruit osteoclast precursor 
cells to the site and induce their differentiation [5, 150], thus initiating the bone resorption 
process. The receptor activator of nuclear factor kappa-B ligand (RANKL) is a key factor for 
osteoclast differentiation and activation [151]. Implant surfaces can affect RANKL-
dependent differentiation in the osteoclast precursor cell line, RAW264.7 [101].  RANKL, 
along with the expression of the decoy receptor, osteoprotegerin (OPG), competitively binds 
to its receptor RANK and induces the differentiation/formation of osteoclasts [152]. The ratio 
of RANKL/OPG expression is responsible for regulation of osteoclast development and 
activity [152] and a recently study  found the RANKL, RANK and OPG expression is 
activated immediately following the placement of implants [153]. Osteocytes are the chief 
source of RANKL in bone remodelling thereby controlling the formation of osteoclasts; 
although other cells types within bone may also  contribute to the pool of RANKL  [112, 151, 
154]  . In vitro results have shown  that MLO-Y4 osteocyte- like cells can support the 
activation of osteoclasts and express RANKL and OPG [155]. Osteocytes undergoing 
programmed cells death also express RANKL by the release of apoptotic bodies, which in 
turn recruit osteoclasts [79]. Interestingly, stimulation of osteocytes by mechanical loading 
has been shown to increase matrix extracellular phosphoglycoprotein (MEPE), an associated 
motif peptide that is seen to possibly upregulate the expression of osteoprotegerin (OPG), 
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resulting in decreased osteoclastogenesis [156]. Using osteocyte-specific β-catenin-deficient 
mice (Ctnnb1(loxP/loxP); Dmp1-Cre) Kramer et al. found significantly decreased OPG 
expression coupled with increased RANKl/OPG ratio and enhanced osteoclastic activity. 
This suggests a dual role for osteocytes in the regulation of bone resorption. The mice had a 
dramatic reduction in both cancellous and cortical bone volume, whereas there was no effect 
on osteoblast or osteocyte numbers or any reduced cell viability [157]. Since the 
osseointegration process involves a RANKL-mediated mechanism and apoptotic osteocytes 
have the ability to simulate osteoclast function [98]. It can be inferred that insults such as 
trauma and heat from the implant placement process itself may initiate osteocyte changes that 
result in osteoclast activation.  
3.2.8 The possible role of osteocyte specific-Wnt/β-catenin pathway in osseointegration 
There are two Wnt-related signal pathways: the canonical Wnt/β-catenin pathway (β-
catenin dependent) and the non-canonical pathway (β-catenin independent). The canonical 
Wnt/β-Catenin signalling pathway is the most extensively studied pathway and controls 
different aspects of bone metabolism by controlling differentiation of bone-forming 
osteoblasts and bone-resorbing osteoclasts  [158, 159]. It is therefore not surprising that this 
is an important pathway in osseointegration. There are as many as 19 secreted Wnt signalling 
molecules, although it is still not clear exactly which of these are involved during bone 
formation [160]. Once an appropriate Wnt protein binds to its cognate receptor(s), which 
include low-density lipoprotein receptor-related protein (Lrp) 5 or Lrp6 and the receptors 
frizzled (FZD), it will trigger the downstream β-catenin pathway The Wnt/β-catenin pathway 
is one of the key pathways whereby osteocytes transmit mechanical signals into the terminal 
target cells [161]. Recently it was found that mechanical loading can affect the bone 
modelling and remodelling around implant [162] and some Wnt ligands, such as Wnt 10b, is 
upregulation during during osseointegration [163], and Wnt3a protein expression is increased 
by the micropitted/nanotubular surface topographies (MNTs) of titanium implants compared 
with smooth surface implant [164] and this protein has been shown to accelerate the rate of 
implant osseointegration [165]. There is also evidence to show that the surface topography 
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and chemistry of implants can affect Wnt signalling, and that implant surface properties can 
change the response of bone cells to Wnt factors [166]. Hydroxyapatite (HA) coated implants 
were placed in rat tibias for 7 or 28 days and showed a significant increase of the Wnt co-
receptors LRP5/6 and WISP1, a downstream target gene of canonical Wnt signalling, 
compared with uncoated Ti [167]. Hence, osteocyte-specific Wnt/β-catenin pathway is very 
likely to have an important role in osseointegration.  
It is quite possible following mechanical loading that an osteocyte-specific Wnt/β-
catenin pathway is activated by crosstalk with the prostaglandin pathway  [89, 168], and that 
this leads to decreased expression of negative regulators of the pathway such as sclerostin 
(SOST) and dickkopf 1 (Dkk1) [161]. Research into negative regulators of Wnt/β-catenin 
pathway have focussed on SOST, Dkk1 and secreted frizzled-related protein 1 (SFRP1), 
which when expressed by osteocytes down regulate bone formation. Sclerostin, the product 
of the SOST gene, is a glycoprotein expressed and synthesized by osteocytes. Sclerostin is a 
competitive co-receptor of low-density lipoprotein receptor-related protein (Lrp) 5/6 (a 
positive regulator of Wnt/β-catenin pathway) and also acts as a BMPs antagonist; and 
therefore has the ability to inhibit osteoblasts activity [169]. Mechanical loading reduces the 
expression of sclerostin [170] and the use of sclerostin antibody treatment has been shown to 
accelerate and enhance the mechanical fixation of medullary titanium/steel or Polymethyl 
methacrylate (PMMA) implants in a rat model by increasing both cortical and trabecular bone 
volume  [171, 172]. Sclerostin can also prevent the particle-induced implant loosening by 
promoting the bone formation at the same time inhibiting the bone resorption [173].  
Dkk1 was originally identified as an antagonist of canonical Wnt signalling by acting 
as an Lrp5/6 inhibitor thereby inhibiting the differentiation of osteoblasts and bone formation 
[157, 174] and is  also  involved in mechano-transduction [175]. In vitro studies show that 
exogenous Dkk1 can cancel out the the differentiation enhancing effects on human MG63 
osteoblasts of micropitted/nanotubular surface topographies (MNTs) titanium implants by 
reducing the activity of the canonical Wnt/β-catenin pathway [164]. Using a Dkk1 
neutralizing antibody (Dkk1-ab) treatment in conjunction with steel implants screwed into rat 
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tibias, there was a significant increasing of bone formation and a significantly greater pull-out 
force was needed to dislodge the implant [175]. Sfrp-1 is another competitive antagonist of 
Wnt ligand binding, and in vivo loss of sfrp1 gene expression increases bone volume and 
density [176]. Sfrp1 is expressed mainly in immature osteocytes, and decreases in mature 
osteocytes Sfrp1 is expressed mainly in immature osteocytes, and decreases in mature 
osteocytes [177]. In vitro results show that loss of Sfrp1 promotes osteoblasts proliferation 
and differentiation into osteocytes [178]. Sfrp1/2 is also expressed at lower levels in MG63 
osteoblasts cultured on MNTs titanium implant, culture conditions which lead to higher 
expression of Wnt3a [164]. 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 4 The theoretical relationship of implant with bone cells. The schematic shows how osteocytes 
are thought to affect osseointegration. Osteocytes control bone resorption by expressing RANKL and M-
CSF, whereas the expression of OPG inhibits osteoclast activity. Osteocytes also secrete factors such as 
PGE2, NO, and ATP that can activate the Wnt/β-catenin signalling pathway and promotes bone 
formation by osteoblasts. On the other hand, osteocytes also release factors such as sclerostin, DKKs, and 
SFRPs, which have an inhibitory effect on Wnt/β -catenin signaling and results in decreased osteoblast 
activity. 
3.2.9 A proposed mechanism of osteocytes in regulation of osseointegration [Fig. 4] 
In the conventional understanding of the biology of implant placement and healing, the 
primary stability is very important for the success of bone healing around the implant. In 
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order to achieve primary stability, the implant bed needs to have a slightly smaller diameter 
than the implant, to achieve a fit between the implant surface and the surrounding bone. This 
will often produce mechanical stress to the surrounding bone tissue including nearby 
osteocytes, thereby triggering the mechanical stimuli and activate Wnt cell signalling 
pathway these osteocytes. The lacuno-canalicular system of osteocytes is an ideal network for 
osteocytes to send signals out for MSC recruitment and osteoblast differentiation. 
Presumably, loading of the bone surrounding the implant when primary stability is acheived 
can affect the bone fluids that would otherwise flow freely through the existing lacuno-
canalicular system. Osteocytes are capable of sensing such changes through the cell body or 
its attached structures [114], and rapidly respond to the stress, including the opening of 
connexion 43 hemichannels, enhanced gap junction functions [74] and activation of the cell 
signalling pathways such as the Wnt/β-catenin, cAMP/PKA [161] and RANKL\OPG related 
pathways [151, 179]. A series of osteoblast related factors such as nitric oxide (NO), 
adenosine triphosphate (ATP), prostaglandin (PGE2), IGF-1 and BMPs as well as osteoclast 
related factors such as RANKL and OPG will be released from the osteocytes to regulate 
osseointegration process.  
3.2.10 Conclusion  
Osteocytes play a dual role in both bone formation and bone resorption. The implant-
healing process is similar in many ways to bone healing, including the activity of osteoblasts 
and osteoclasts. Exploring the mechanism of how osteocytes regulate the bone healing 
process around implants would significantly enhance our understanding of osseointegration 
of dental implants.    
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4.1 Abstract 
The effects of estrogen deficiency on bone characteristics are site-dependent, with the 
most commonly studied sites being appendicular long bones (proximal femur and tibia) and 
axial bones (vertebra). The effect on the maxillary and mandibular bones is still inconsistent 
and requires further investigation. This study was designed to evaluate bone quality in the 
posterior maxilla of ovariectomized rats in order to validate this site as an appropriate model 
to study the effect of osteoporotic changes.  
Methods: Forty-eight 3-month-old female Sprague-Dawley rats were randomly divided 
into two groups: an ovariectomized group (OVX, n=24) and Sham-operated group (SHAM, 
n=24). Six rats were randomly sacrificed from both groups at time points 8, 12, 16 and 20 
weeks. The samples from tibia and maxilla were collected for Micro CT and histological 
analysis. For the maxilla, the volume of interest (VOI) area focused on the furcation areas of 
the first and second molar. Trabecular bone volume fraction (BV/TV, %), trabecular thickness 
(Tb.Th.), trabecular number (Tb.N.), trabecular separation (Tb.Sp.), and connectivity density 
(Conn.Dens) were analysed after Micro CT scanning. 
Results: At 8 weeks the indices BV/TV, Tb.Sp, Tb.N and Conn.Dens showed significant 
differences (P<0.05) between the OVX and SHAM groups in the tibia. Compared with the 
tibia, the maxilla developed osteoporosis at a later stage, with significant changes in 
maxillary bone density only occurring after 12 weeks. Compared with the SHAM group, both 
the first and second molars of the OVX group showed significantly decreased BV/TV values 
from 12 weeks, and these changes were sustained through 16 and 20 weeks. For Tb.Sp, there 
were significant increases in bone values for the OVX group compared with the SHAM 
group at 12, 16 and 20 weeks. Histological changes were highly consistent with Micro CT 
results. 
Conclusion: This study established a method to quantify the changes of intra-radicular 
alveolar bone in the posterior maxilla in an accepted rat osteoporosis model. The degree of 
the osteoporotic changes to trabecular bone architecture is site-dependent and at least 3 
months are required for the osteoporotic effects to be apparent in the posterior maxilla 
following rat OVX.  
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4.2 Background 
Osteoporosis (OP) is a systemic disease that affects over 200 million people worldwide 
[1, 2]. It is characterized by a decrease in bone mass and strength that predisposes the bone to 
fracture, and negatively influences the bone healing process [3, 4]. In order to better 
understand the biological mechanism associated with osteoporosis, ovariectomized rats have 
been widely used as a model to simulate human postmenopausal osteoporosis. 
Ovariectomized rat and osteoporotic human bone share many characteristics, including an 
increased rate of bone turnover with resorption exceeding formation, an initial rapid phase of 
bone loss followed by a much slower phase; greater loss of cancellous bone than cortical 
bone; and similar skeletal response to therapy with pharmaceuticals [5]. Other important 
reasons for utilisation of a rat model include cost-effectiveness, as well as ease of handling 
and housing, when compared with other models of osteoporosis, especially those involving 
large animals[6]. 
The healing of fractures of long and axial bones has been shown to be negatively affected 
by osteoporosis [4]. In relation to oro-dental conditions, clinical studies have revealed 
positive correlations between periodontitis and estrogen deficiency [7-10], tooth loss and 
osteoporosis [8, 11, 12], delayed alveolar bone wound healing and increased severity of 
residual alveolar ridge resorption caused by estrogen deficiency. [13, 14].     
The effects of estrogen deficiency on bone parameters such as size, mass and density are 
site-dependent [15]. The most widely investigated sites for osteoporotic bone loss are 
appendicular long bones (proximal femur and tibia) and axial bones (vertebra), and the 
changes reflected in bone morphometric parameters are well characterized in these areas [15, 
16]. It appears that there is an inherent genetic difference between bones of cranial and non-
cranial origin [17], which is not surprising given the differences in embryological origin and 
mechanisms of ossification. According to Ishihara et al, bone loss following ovariectomy 
predominantly occurs in those areas formed by endochondral ossification, such as the distal 
femur, rather than in areas formed by intramembranous ossification, such as the maxilla [18]. 
Mavropoulos et al. also reported a reduced response in the mandibular to estrogen deficiency 
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in rats, when compared to other skeletal sites [19], and other animal studies have produced 
similar results [20, 21]. However, some animal studies have reported positive correlation of 
osteoporosis and alveolar bone changes, as well as periodontal bone loss [7, 9, 10, 14]. 
Therefore, there is a clear need to clarify the effect of estrogen deficiency on maxillary and 
mandibular alveolar bones. Given trabecular bone is believed to be more susceptible to be 
affected by estrogen deficiency than cortical bone [22], maxillary bone, especially the porous, 
posterior maxillary region may be regarded as a more sensitive location for estrogen 
deficiency, compared with mandibular bone [23]. However, most researchers have used the 
rat mandible rather than the maxilla as the site of choice to study estrogen related bone loss 
following ovariectomy [19, 20, 24-26]. This may be due to the simpler geometry of the 
mandible, which makes it easier to determine bone volume when compared with the maxilla, 
which is characterized by irregular, more complicated roots and the presence of the maxillary 
sinus.  
Traditionally, the main methods used for analysing bone characteristics are 
histomorphometry and/or 2 dimensional (2D) radiography (including Dual Energy X-Ray 
Absorptiometry, DEXA).  DEXA mainly focuses on bone density (BMD) and is not an 
optimal tool when used in the presence of excess adipose tissue [27] and is also a challenge 
with growing animals [6]. On the other hand, histological assessment has the inherent 
limitation of only reflecting an isolated site, rather than whole bone changes [6]. 3D micro 
CT analysis has been used to overcome these limitations to obtain conclusive research 
outcomes [1, 28-30]. Although 3D Micro CT has been used by a few researchers to analyse 
mandibular bone [31, 32], it has not been used for analysis of maxillary bone changes due to 
the lack of method to extract the volume of interest (VOI) areas in maxilla. Therefore, this 
study was undertaken to compare maxillary and tibial bone morphometric parameter changes 
resulting from estrogen deficiency induced by ovariectomy. Micro CT and histological 
analysis were used to evaluate bone changes at different time points over a period from 8 to 
20 weeks post-ovariectomy.  
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4.3 Materials and Methods 
     Animals 
     Forty-eight 3-month-old female Sprague-Dawley rats, weighing 232–267g, were 
obtained from an animal resource centre (SLAC Laboratory Animal Co. Ltd, Shanghai, 
China). The animals were randomly divided into two groups: an ovariectomized group 
(OVX, n=24) and Sham-operated group (SHAM, n=24). The ovariectomy operation was 
performed according to methods described in our previous study [33]. Briefly, the ovaries of 
the rats were exteriorized safely after ligature was placed at the end of fallopian tube; for the 
SHAM group, the same size of fats tissue near the ovaries was removed. The muscle and skin 
were sutured in layers. Six rats per group at different time point were sacrificed at 8, 12, 16 
and 20 weeks, after ovariectomy or sham operation. One tibia and one maxilla from each 
animal were randomly selected for Micro CT analyses, while the contralateral bones were 
prepared for histological analysis. All animal research protocols were approved by the 
Animal Care and Use Committee of Fujian Medical University and are similar to our 
previous studies [33]. (Fig.1) 
 
 
 
 
Fig. 1: The research timeline. Animals were subjected to ovariectomy or sham surgery at the age of 
12 weeks and sacrificed at 8, 12 16 or 20 weeks after surgery. 
 
Micro CT evaluation 
Bone histomorphometric parameters and the microarchitectural properties of maxilla and 
tibia were evaluated using a micro-CT system ((μCT 40; Scanco Medical AG, Bassersdorf, 
Switzerland)). The bones were scanned at an energy of 70 kV and intensity of 114 µA, with 
300 ms integration time, resulting in 16-μm isotropic voxel size. For the scanned tibia, the 
volume of interest for evaluation of bone morphometric parameters was chosen over 200 
slices, starting 25 slices distal from the growth plate. The trabecular bone compartment was 
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determined using a semi-automatic algorithm. 
For the posterior maxilla, the scaned area of interest included three molars. The volume 
of interest (VOI) region focused on the furcation areas of the first molar and second molars. 
Initially,  a circle with 40 pixel (0.64 mm) diameter was selected at the most coronal aspect of 
the root furcation, and after a further 40 slices apically a circle was selected with 60 pixel 
(0.96 mm) diameter. A third circle with the same diameter was then selected after another 60 
slices and eventually, the VOI was defined by morphing across the slices between these three 
circles, forming an irregular, conical cylinder. Trabecular bone volume fraction (BV/TV, %), 
trabecular thicknesses (Tb.Th.), trabecular number (Tb.N.), trabecular separation (Tb.Sp.), 
and connectivity density (Conn.Dens) were determined for VOI using the micro CT 
evaluation software SCANCO (Scanco Medical AG, Bassersdorf, Switzerland) provided with 
the micro-CT system [34]. (Fig.2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: (a) shows the definition of VOI from microCT scans; (b) shows first (1st) circle with 40 
pixel diameter from the beginning of furcation area underneath the molar (first circle); (c) shows second 
circle (2nd circle) with 60 pixel diameter after 40 sections from the first circle in furcation area; (d) is the 
trabecular bone fraction underneath this molar after the slices between these circles were morphed, 
resulting in an irregular, conical cylinder as VOI . 
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Histology 
Samples for histological evaluation were fixed after sacrifice in 70% alcohol. Further 
processing of the samples was carried out according to routine methods.  Briefly, the samples 
were dehydrated in a series of graded alcohol, then embedded in methylmethacrylate (MMA) 
(Merck, Darmstadt, Germany) acording to the manufacturer’s instructions. Slices of 10 to 
m thickness were obtained using an Exakt cutting- grinding system (EXAKT 
Apparatebau,. Norderstedt, Germany ). Sections were stained using toluidine blue or 
Methylene Blue – Alizarin Red and scanned using Aperio microscope (Aperio, Vista, CA, 
USA). Trabecular bone volume fraction (BV/TV, %) at 12 weeks was analysed by the 
system’s image analysis software (Aperio, Vista, CA, USA).  
Statistical analysis 
Data are expressed as means ± standard deviations. One-Way ANOVA was used to 
compare body weights and identify significant differences between tibia and maxilla at 
different time points in the OVX and SHAM groups. p values of <0.05 were considered 
significant. 
 
4.4 Results 
Body Weight 
Generally, ovariectomy resulted in weight gain. At baseline, there were no differences in 
weight between the two experimental groups. However, after ovariectomy, the body weights 
changed significantly. The weight of the animals from the OVX group was higher compared 
with the SHAM group at all evaluated time points (8, 12, 16 and 20 weeks respectively) 
(Fig.3).   
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         Figure 3: Analysis of body weights showed significantly higher body weights in OVX treated rats 
from 8 weeks throughout entire experimentation period. 
 
Micro CT Assessment 
For the tibia, OVX rats had reduced quality trabecular bone structures compared with 
SHAM operated rats at both 8 and 12 weeks (Fig.4 a, b). After 8 weeks, BV/TV (Fig.5 a) was 
significantly decreased compared with the SHAM group. The same trends were seen for 
Tb.N (Fig.5 d) and Conn.Dens (Fig.5 e), as trabecular bone of the OVX group was 
significantly declined, compared with that of the SHAM group. For Tb.Sp (Fig.5 b), the OVX 
group achieved significantly higher values than the SHAM group, while no differences were 
found between the two groups for Tb.Th (Fig.5 c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: 3D micro CT (a, b) and histology images (c, d) of tibia at 8 weeks. Compared with SHAM 
group (b, d), OVX treated rats (a, c) had significantly less trabecular bone. Rats’ trabecular bone of tibia 
has significantly decreased (Scale bar=1mm). 
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Figure 5: Micro CT results of tibia showed significant differences from 8 weeks for the parameters 
BV/TV (a), TbSp. (b), Tb.N.(d), and Conn.dens (e), but no differences could be determined for the 
parameter Tb.Th. (c) 
In the maxilla, significant changes in bone density only occurred after 12 weeks, in 
contrast to the tibia where these changes were already evident at 8 weeks. The 3D images of 
the first (Fig.6a, b) and second (Fig.6 c, d) molar furcation areas at 12 weeks showed more 
poreous structure in the OVX group (Fig.6 a, c) compared with the SHAM group (Fig.6 b, d). 
Compared with the SHAM group, both the first and second molars of the OVX group showed 
significantly decreased BV/TV (Fig.7a, 8a) from 12 weeks, and these changes were sustained 
through 16 and 20 weeks. For Tb.Sp (Fig.7b, 8b), the ovarietomy caused significant increases 
in bone morphometric values for the OVX group compared with the SHAM group at 12, 16 
and 20 weeks. For the other parameters (Tb.Th, Tb.N, Conn.dens), the changes were not 
always consistent between the two molars at the same time points. For Tb.Th, at the first 
molar, the ovariectomy caused statistically significant reductions of trabecular numbers at 12, 
16 and 20 weeks (Fig.7c), but for the second molar, significant changes were only observed 
at 16 and 20 weeks (Fig.8c). For Tb.N, there were significant differences at 12 and 16 weeks 
in the first molar (Fig.7d), but only at 12 and 20 weeks for the second molar (Fig.8d). For 
Conn.dens, the findings were more variable. At the first molar site, the OVX group had a 
higher value compared with the SHAM group at weeks 8 and 16 weeks (Fig.7e). These 
inconsistent changes were also measured at the second molar site,  where OVX group had a 
Rat osteoporotic maxilla model study  Page 58 
 
statistically significant increase in Conn.dens at week 16 and 20 (Fig.8e). The detailed 
evaluation of micro CT results was in supplimental data Table 1-3 (see appendix).  
 
 
 
 
 
 
 
  
 
 
 
Figure 6: 3D micro CT images of the first molar (a, b) and second molar (c, d).  Compared with 
SHAM group (b, d), the bone in OVX group (a, c) is more porous at 12 weeks. 
 
 
Figure 7: Micro CT results of first molar showed significant differences from 12 weeks for the  
parameters BV/TV (a), Tb.Sp (b), Tb.Th (c) and Tb.N (d).  However, for the parameter Conn.Dens (e), 
the differences between the two experimental groups were not consistent across the examined time points. 
Note the difference between the results for Tb.Th (c) between the maxilla here and the tibia (Fig.4c). 
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Figure 8: Micro CT results of second molar showed significant differences between the groups for 
the parameters BV/TV, Tb.Sp, and Tb.N. from 12 weeks after surgery. For Tn.Th , the difference 
between the groups was statistically significant from 16 weeks.  Also for the parameter Conn.Dens, the 
differences between the two experimental groups were not consistent across the examined time points. 
Note the difference of index Tb.Th compared with tibia (Fig.4c). 
 
Histological Assessment 
The histology images of tibia at 8 weeks showed significantly more sparse trabecular 
bone in OVX rats compared with the sham group (Fig.4 c,d), which is consistent with the 3D 
micro CT results (Fig.4 a, b). In summary, these results provide evidence that bone loss due 
to estrogen deficiency induced by ovariectomy surgery affected long bone as early as 8 
weeks. 
The evaluation of the histology images from the maxilla showed that the trabecular bone 
was affected by the overiectomy operation at week 12, with the OVX group having increased 
bone marrow volume (Fig.9a) compared with the SHAM group (Fig.9b), which was 
consistant with the micro CT’s longitudinal sections (Fig.9c=OVX, 9d=SHAM) and the 3D 
micro CT results (Fig.6). The analysis of trabecular bone area showed higher values for the 
SHAM group compared to the OVX group (Fig.9e, P<0.05). The microscopic evaluation of 
histological sections highly supported the findings from micro CT. 
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Figure 9: Histology images (a, b) and micro CT longitudinal sections (c, d) of Maxilla at 12 weeks 
showed similar changes. Compared with SHAM group, OVX group has been significantly lower bone 
volume (P<0.05), with less trabecular bone and more bone marrow (e). (Scale bar=2mm) 
 
4.5 Discussion 
The impacts of osteoporosis on the dental health of patients are not clear-cut.  However, 
the negative impacts on the dental health of patients undergoing certain treatments for 
osteoporosis are known. The ovariectomised rat is a frequently used model for osteoporosis 
recommended by the U.S. Food and Drug Adminstration (FDA) [35] owing to advantages 
including similar changes in bone metabolism during estrogen deficiency compared with 
humans [5], easy and safe handling and a low cost of acquisition [6]. However, the question 
of whether the rat’s maxillary and/or mandibular bone can be used to study osteoporotic bone 
loss compared with the routinely used long bones or vertebrae is still a controversial issue 
[36]. In the present study, we examined the effects of ovariectomy induced estrogen 
deficiency on the bone of the posterior maxilla, with the aim of validating its suitability as a 
model for studying the effects of osteoporosis on oro-dental conditions and procedures.  
Methods used for the analysis of bone density can be divided into destructive and non-
destructive methods. Compared with the well-established method of histomorphometry, the 
newer non-destructive micro CT method is based on building full three-dimensional 
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structures of the sample [37]. The use of this method effectively avoids potential variability 
by observers [38] and accounts for bone parameters varying within a given specimen [39]. 
Dual energy X-ray absorptiometry (DEXA) is another method that is regularly used to 
investigate bone density. But due to the low resolution and the limitation of 2 dimensional 
imaging, DEXA is not able to determine microstructural parameters [21]. Theoretically, the 
ideal way to analyse maxillary bone using micro CT would be to include the whole bone and 
exclude the tooth roots. However, this is very difficult to implement because of the irregular 
shape of maxilla and tooth roots, as well as the presence of the sinus and nose cavities. These 
difficulties may explain the lack of studies evaluating maxillary bone changes resulting from 
osteoporosis in the literature. The furcation area, which is entirely made up of trabecular bone, 
is an important site to reflect the impact of osteoporosis on bone quality. The furcation areas 
are also involved in periodontal disease and act as a recipient site in dental implant placement. 
Therefore, the furcation areas of the first molar and second molars were selected for micro 
CT analysis, assuming that any changes to the trabecular bone in the area would be 
representative of changes in the remainder of the maxilla. The third molar was not included 
because of the large variation of roots between animals and the difficulties to generate 
consistent and reproducible evaluation.  
From our results, both animal weights and the trabecular bone content of the tibia in the 
OVX group were significantly different at the first observation time point of 8 weeks. 
Ovariectomy caused accelerated food intake which resulted in body weight increase, which is 
consistent with other reports in the literatures [21]. Ovariectomy also caused significant tibial 
trabecular bone loss in the OVX group compared with the SHAM group from 8 weeks. Bone 
volume fraction (BV/TV), Tb.N, and Conn.Dens were significantly decreased compared with 
the SHAM group. This meant that at 8 weeks, induction of the osteoporosis model in the tibia 
could be deemed as being successfully achieved, as has been described previously [40].  
 
However, in maxilla, the decrease in bone density did not emerge until 12 weeks, as 
opposed to 8 weeks in the tibia. From 12 weeks in the maxillary groups, BV/TV showed a 
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significant decrease and Tb.Sp increased significantly in the OVX group compared with the 
SHAM group. The furcation areas of the first molar and second molar in the OVX group 
showed more porous compared with the SHAM group. Histological analysis and micro CT 
results also showed the same trend. The apparent difference of osteoporotic effect on maxilla 
and tibia following ovariectomy can be explained by the different embryological origins and 
different ossification processes between the two anatomic locations [19]. Additionally, the 
asynchronism may be explained by inherent genetic differences between bone of cranial 
origin and bone of non-cranial origin [17]. Our research clearly demonstrated that an 
osteoporotic state was reached in the maxilla, albeit at a delayed rate concurrently, in the long 
bone.  
Another interesting finding is that the parameters used for the analysis of bone tissue 
architecture did not reveal the same changes between tibia and maxilla. In the tibia, the 
trabecular bone thickness (Tb.Th) showed no obvious differences between the two groups. 
However, in the maxilla, OVX caused bone trabeculae to become significantly thinner than in 
the SHAM group and the differences did not emerge at the same time point in the two regions 
evaluated in the maxilla (between first and second molar furcation areas). Connectivity 
density (Conn.Dens) in the tibia of OVX animal decreased from 8 weeks, but in the maxilla, 
there was no regular pattern for either the first or second molar. We speculate that this could 
be due to the different endochondral and membranous bone formation between long bones 
and maxillar/mandibular bones [19]. The complexity of the masticatory force distribution 
between the different teeth could also result in subtle structural differences between the first 
and second molars.  
The maxilla is an irregularly shaped bone due to the presence of the sinus and nasal 
cavity in the molar area, which makes the micro CT analysis challenging, because it is almost 
impossible to acquire a standard reproducible shape of VOI for all specimens to be analysed. 
Before we chose the furcation areas for analysis, we tried to assess the entire maxilla, except 
for the teeth. But we found that either tissue from the VOI was incorrectly omitted, or it was 
otherwise very challenging to obtain a consistent shape between different rats. Consequently 
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we selected the furcation area for the analysis. Initially we wanted to include the molar 
furcation areas from all three molars, but the roots of the third molar have significantly 
different shapes between animals, so we only selected the first molar and second molar for 
our analysis. By choosing a conical cylindrical shape for our VOI in the furcation area, 
defined by three circles with diameters of 40, 60, and 60 pixels respectively, we were able to 
completely exclude the roots. However, it should be noted that this method may result in the 
exclusion of some trabecular bone from the analysis. While this represents a limitation of our 
research, it is positively comparable with limitations faced by other researchers who have 
previously attempted to identify the changes of mandibular bone as a result of osteoporosis, 
whether it was based on 2D X-ray [41-43] or 3D CT [44-46]. All of these studies were 
challenged by the difficulty of acquiring a standard VOI for comparison between animals and 
between experimental groups. We believe that the creative method developed in this study 
for defining the VOI’s in the maxilla may also be used for other applications in bones of 
irregular shape. 
 
4.6 Conclusion 
It appears that the trabecular bone compartment in the tibia is more sensitive than the 
maxilla to changes in estrogen levels as induced in rats by ovariectomy, demonstrating that 
the effects of estrogen deficiency on trabecular bone architecture are site-dependent and at 
least 3 months are required for the osteoporotic effects to be apparent in the posterior maxilla 
following rat OVX. A key outcome of this study is the establishment of a method to 
reproducibly define a standardised VOI in the posterior maxilla for the evaluation of 
trabecular bone morphology, which may also be used for bones with irregular shape.   
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5.1 Abstract 
Objectives: Published information regarding the use of rat jawbones for dental implant 
osseointegration research is limited and often inconsistent. This study assessed the suitability 
and feasibility of placing dental implants into the rat maxilla and to establish parameters to be 
used for dental implant research using this model.  
Materials and methods: Forty two customised titanium implants (2×3mm) were placed 
bilaterally in the maxillary first molar area of 21 Sprague-Dawley rats. Every animal received 
2 implants. The animals were subsequently sacrificed at days 3, 7, 14, 28 and 56 post-
surgery. Resin-embedded sections of the implant and surrounding maxilla were prepared for 
histological and histomorphometric analyses.  
Results: The mesial root of the first molar in the rat maxilla was the optimal site to place 
the implant. Although the most apical 2-3 threads of the implant penetrated into the sinus 
cavity, 2mm of the remaining implant was embedded in the bone. New bone formation at day 
7 around the implant increased further at day 14, as measured by the percentage of bone-to-
implant contact (%BIC) and new bone area (%BA) in the implant thread chambers (55.1 ± 
8.9% and 63.7 ± 7.7% respectively). There was a further significant increase between day 14 
and 28 (p<0.05), however no significant differences were found between day 28 and 56 in 
either %BIC or %BA.  
Conclusions: The mesial root socket of the first molar in the rat maxilla is a useful 
model for dental implant research. Osseointegration following implant placement as 
measured by BIC plateaued after 28 days. The recommended implant dimensions are 1.5mm 
in diameter and 2mm in length. 
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5.2 Background  
The widespread acceptance of dental implants as a feasible option for the rehabilitation 
of patients who have lost their teeth as a result of disease, pathology or trauma, has driven 
significant research activity aimed at improving their effectiveness. To this end, modification 
of the implant surface [1, 2], configuration [3] and/or implant material [4, 5], have all been 
rigorously assessed as a means to improve the ability of implants to osseointegrate. More 
recently, the undesirable effects of systemic disease (e.g. diabetes and osteoporosis) on the 
osseointegration of implants have also been examined [6-8].  
In order to assess the effects of these parameters on osseointegration and bone 
regeneration, various animal models have been routinely used before proceeding to human 
clinical trials. Small animals such as rodents (mice, rats, rabbits) are often used before 
moving to larger animal (dogs, sheep, pigs, primates) studies. Of these animal models, rats 
are the most frequently used medical model compared with other animal models [9], not only 
because of their cost effectiveness, easier handling and lesser laboratory space requirements, 
but also because  they can be used to mimic human diseases such as osteoporosis [10] and 
diabetes [11, 12]. Notwithstanding these advantages, there are still some significant 
limitations in the use of small animal model systems in dental implant osseointegration 
research, such as technical difficulties associated with anatomical constraints [13], and the 
identification of a  suitable implant site [13-15]. 
Historically, the most common site for placement of a dental implant in small animal 
models such as the rat has been the femur or tibia [7, 16-18] as these sites are relatively easy 
to access surgically and have sufficient amounts of bone tissue to embed the implant. 
However, significant differences in the embryological origin and ossification processes of 
long bones in comparison to craniofacial development [19, 20] warrants caution in translating 
the results obtained in a long bone model to the oral environment. 
While a number of previous studies have utilised the rat maxilla to assess the 
osseointegration of dental implants, differences in the site and implant used make it difficult 
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to assess the validity of this model [13-15, 21-35]. Of these studies, most of the implant sites 
selected were in the first molar area and the diameter of Implants used varied between 1 and 
4.5mm. Methodology regarding implant placement however was often deficient and the 
results rarely mentioned the complications / limitations relating to the use of the maxillary 
site for implant placement. Moreover, only a few of these studies used resin embedded 
samples to analyse the degree of osseointegration as measured by the percentage of bone to 
implant contact (%BIC).  
The aim of the present study therefore, was to comprehensively assess the temporal 
changes in bone-implant contact during implant osseointegration in the rat 1
st
 maxillary 
molar post-extraction socket in order to establish its suitability as a model for dental implant 
research. 
 
5.3 Materials & Methods 
Animals 
Twenty three three-month-old female Sprague-Dawley rats, weighing 245–279g were 
obtained from the Animal Resource Centre (Murdoch Drive, Murdoch, Western Australia). 
Two rats per cage were housed at the University animal facility in temperature (22±2
0
C) and 
humidity (50±20%) controlled rooms with a 12 hr light and dark cycle. Commercial 
laboratory rat chow and water were available ad libitum throughout the study. The animals 
were acclimatised within the facility for one week before any surgical procedures were 
performed. The Griffith University Animal Ethics Committee (DOH/01/4/AEC) approved the 
research protocol. 
To identify potential implant sites, two of the rats were sacrificed by anaesthetic overdose 
and their maxilla scanned by micro CT (μCT 40; Scanco Medical AG, Bassersdorf, 
Switzerland). The ultimate implant design was subsequently based on these micro-CT 
analyses. 
Implants 
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Moderately rough (Ra ≈ 1.27μm) titanium screw implants were custom produced by 
Southern Implants Ltd (Irene, South Africa). The implants (2mm in diameter and 3mm long) 
were produced from Type IV commercially pure titanium and using the same processes as 
those utilized  in commercially available implants.  
Surgical procedures 
The surgical procedures are shown in figure 1(a-d). Twenty-one rats were anesthetized 
by Isoflurane (1–3%) inhalation and kept on heating pads to maintain body temperature 
during surgery.  The oral cavity was first cleansed with 0.12% chlorhexidine gluconate before 
using a retractor to open the mouth and a crestal incision (approximately 2mm long) made at 
the mesial aspect of the first maxillary molars. A full thickness mucoperiosteal flap was 
raised in order to identify the most mesial root of the tooth. The 1
st
 molar teeth were then 
extracted using a modified spatula and toothed forceps that were used as a root elevator and 
extractor forceps respectively.  
The mesial root sockets were then inspected and a small dental curette was used to 
remove any residual root fragments. Only the mesial root needed to be completely removed 
for implant placement. 
Initially, a 1.2mm diameter pilot drill (Southern Implants, Ltd., Irene, South Africa) was 
used to create the osteotomy to a depth of 2.5 - 3.0mm with a rotary speed not exceeding 
1500 rpm. The final osteotomy was completed with a 1.8 mm diameter drill (Southern 
Implants, Ltd., Irene, South Africa). All osteotomy procedures were performed with copious 
saline irrigation. An implant was placed into each socket with a torque of 15-20Ncm until the 
most coronal parts of the implant coincided with the bone crest and primary stability was 
achieved. The flap was then closed with resorbable sutures (5/0 Vicryl) and the implant was 
fully submerged. No cover-screw or a healing abutment was used in this procedure.  
The rats were then allowed to recover on the thermal pad. Post-operative analgesia 
(buprenorphine 0.01 - 0.05mg/kg and carprofen 4 - 5mg/kg) and antibiotic cover 
(enrofloxacin 2.5mg/Kg) were administrated by intraperitoneal injection immediately after 
the surgery and continued daily for three days post-operatively. After surgery, the rats were 
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given standard rat chow and water ad libitum. The animal’s weight was monitored daily to 
determine if there were any complications in feeding as a result of the bilateral molar 
extraction and implant placement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Shows the surgical procedures. (a) and (b) extraction of the teeth. (c) preparation of the 
osteotomy. (d) implant placement at level of the alveolar bone. (e) and (f) x-ray of implant in position. 
 
Histological  Preparation 
Animals were sacrificed after 3, 7, 14, 28 and 56 days of healing (n=3 for days 3 and 7, 
n=5 for days 14, 28 and 56). Specimen blocks of the maxilla surrounding the implants were 
carefully harvested using a diamond-tipped circular saw with irrigation and immediately 
fixed with 4% paraformaldehyde for 48h at 4°C. The samples were then dehydrated in a 
graded series of ethanol before embedding in methylmetacrylate resin (Technovit® 7200 
VLC, Heraeus Kulzer, Dormagen, Germany).  
Sections 140 - 200 microns thick of the maxilla containing the implant were cut bucco-
palatal and parallel to the long axis of implant using the EXAKT cutting system. The sections 
were prepared as close to the centre of the implant possible which allowed 2 sections per 
implant to be prepared. These sections were then gradually ground to 30-microns in thickness 
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using the EXAKT grinding system  (EXAKT Apparatebau, Norderstedt, Germany) [7, 36]. 
The sections were stained with methylene blue-alizarin red S and scanned using the Aperio 
ScanScope CS at x40 magnification (Aperio Technologies Inc., Vista, CA). 
Histomorphometric analysis 
The BIC and BA were traced from the scanned images. Histomorphometric analysis of 
each specimen was then determined using ImageScope software (Aperio Technologies 
Inc). The percentage BIC is defined as the ratio of the sum of the implant surface in direct 
contact with bone tissue and the total length of the implant adjacent to native bone (Fig. 2). 
The bone area (BA) was defined as the fraction of mineralized bone tissue excluding any 
non-mineralised tissue within the threaded areas of the implant that were adjacent to native 
bone. The dimensions of the native bone from both buccal and palatal aspects were also 
measured. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The percentage BIC is defined as the ratio of the sum of the implant surface in direct contact 
with bone tissue (total length of the red dashed lines) and the total length of the implant (total length of 
the green dashed lines) adjacent to native bone. The adjacent native bone is shown as the areas between A 
& C and B & D. Any bone formation in the sinus area (blue area) is excluded. 
 
Statistical analysis 
Data is expressed as the mean +/- the standard deviation. The data were tested for 
normality using the Kolmogorov-Smirnov test, while the homogeneity of variance was 
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verified using Bartlett’s test. Subsequently One-Way ANOVA was used to compare 
differences in the amount of BIC and BA at the sacrificial time-points using Tukey’s HSD 
test. A p-value of <0.05 was considered significant. 
5.4 Results  
Anatomy and Micro-CT Analysis 
Analysis of the initial two rat skulls (Fig. 3a, b) showed that there were three aligned 
molars posterior to the base of the zygomatic bone. The alveolar bone was obviously 
protuberant on the buccal side in order to accommodate the anatomy of the roots. No 
boundary between the sinus and nose cavity was observed and they appeared to merge to 
form a single cavity. Two large dehiscences (bony slits) were located oblique and anterior to 
the first molar. The widest horizontal dimension was located anterior to the maxillary first 
molar where the bone was approximately 3mm wide. Micro-CT analysis (Fig. 3c) 
demonstrated that the first molar in the rat maxilla has five roots, the largest of which was the 
mesial root with a length of 3mm and a diameter of 1-2 mm (Fig. 3d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Shows the anatomical relationship of the first molar and its mesial root(yellow line) with the 
maxilla. (a) shows the outline of maxilla,  (b) shows the molar area of maxilla, red dotted line shows the 
widest width of  the alveolar bone is located between the bottom of zygomatic arch and mesial root of first 
molar. Purple arrow shows the dehiscence in the anterior palate. (c) Longitudinal micro CT image of 
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maxilla shows the mesial root of the first molar is the largest of the roots.  (d) shows the length of mesial 
root is nearly 3mm. 
Based on these morphometric measurements, 2mm diameter x 3mm long customised 
implants were manufactured by Southern Implants Ltd (Irene, South Africa) with the same 
material, surface modification and manufacturing processes used in full sized human 
implants (Fig. 4). Subsequent morphological analysis of the maxilla from rats that received 
implants however, demonstrated that in some animals, the vertical dimension of the alveolar 
bone in this region was approximately 2mm. This meant that the most apical 2-3 threads of 
the implant could penetrate into the sinus cavity (Fig. 5). 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Customized moderate rough (Ra=1.27μm) surface implant made according to the anatomical 
characteristics of the mesial root of the first maxillary molar. (a) shows the design draft of the implant, (b) 
shows the implant surface under scanning electron microscope (SEM). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5(a). Morphometric analysis shows the implant placed into the first molar position. (b) shows the 
alveolar bone height near the implant position was nearly 2mm. (c) shows 2-3 threads of the implant 
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penetrated into the sinus. (d) shows the implant was placed slightly to the palatal side. The ideal position 
should be as indicated by the yellow circle (i.e. more towards the buccal than palatal side). 
 
Histological and Histomorphometric analysis 
Post-operatively, all animals tolerated the surgical procedures without any obvious 
complications. After 3 days of healing, histological analysis showed that the implant 
remained in close contact with the walls of the recipient bone but no obvious new bone 
formation around the implant was observed. Whilst some pieces of fractured bone tissue were 
observed within the thread areas of the implant, no bone resorption was apparent (Fig. 6a). 
After 7 days of healing, new bone formation, both directly on the implant surface and from 
the parent bone was observed. While pieces of the fractured old bone still remained in some 
of the inter-thread areas, within the new bone, osteoblasts could be clearly identified. Bone 
healing at this time however was not completely consistent as some areas of the old bone 
around the implant showed bone lacunae that could have been the result of osteoclastic 
activity (Fig. 6b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.  Shows new bone formation at day3 (a) and day7 (b).  At day 3, the implant was mechanically 
integrated with bone tissue (green arrow), with pieces of fracture bones seen in-between the threads.  At 
day 7 new bone had grown into some threaded areas (blue arrow) (bar=200µm).  
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After 14 days of healing, new bone formation was observed both on the implant surface 
and at the interface of the resorbed old bone (Fig. 7a). There were abundant osteoblasts 
located in the new bone surface and many osteoclast lacunae were still clearly present, 
although fewer than observed at day 7 (Fig. 7b, c). The mean percentage bone-to-implant 
contact (%BIC) and bone area (%BA), in the threaded regions of the implant at this timepoint 
was 55.1 ± 8.9% and 63.69 ± 7.7% respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7(a). Shows the day 14 histology results. More new bone was seen compared to day 7. (b)There 
were obvious osteoblasts arranged in the new bone surface (red arrows ). (c) In the old bone areas, 
osteoclasts could be clearly seen (green arrows).(a, bar=200µm; b&c, bar=50µm). 
 
The mean BIC (71.1 ± 13.7%) continued to increase significantly (p<0.05) over the next 
14 days. Similarly, the percentage of new bone area (77.1 ± 5.3%) within the threaded 
chambers of the implant at day 28 also increased significantly compared with day 14 
(p<0.05) (Fig. 8). Compared with the appearance of the newly formed bone at day 14, the 
woven bone in the threaded areas also appeared more dense and mature at day 28 (Fig. 8a, b). 
At the final healing time-point 56 days post-surgery, the bone around the implant could 
now be considered mature. Osteoblasts and osteoclast lacunae only appeared in areas 
undergoing remodelling. Some samples clearly showed the border between the old and new 
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bone, but generally the osteocyte arrangement was more regular compared with day 28 (Fig. 
8c,d). Furthermore, there were no significant further changes in either %BIC or %BA at day 
56 compared with day 28 (Fig. 8 e,f). 
A notable observation was that, depending upon the individual animal and the precise 
positioning of the osteotomy, the implant could penetrate into the sinus floor leaving only 
2mm of the remaining implant embedded in the bone (Fig. 4, 9a). Histological analysis of the 
perforated areas however showed that there was usually obvious new bone formation around 
the sinus-embedded apical region of the implant (Fig. 9a). The average height of the 
maxillary bone on the buccal (1.8 ± 0.3mm) and palatal (1.5 ± 0.2mm) sides of the implant 
were also shown to be significantly (p<0.05) different (Fig. 9b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8(a, b).  Histological results day 28. (c, d) Histological results day 56. At day 56, the bone appears 
to be more dense and mature. The bone between the original alveolar bone and that between the implant 
threads (between the green and blue lines) can be seen to be becoming gradually more mature.  The 
osteocyte arrangement also appears to be better than that at day 28. (e, f) Compared with day 14, 
the %BIC and %BA were significantly increased (*p<0.05), but there were no further significant 
differences between day 28 and day 56 (a & c, bar=200µm; b & d, bar=100µm). 
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Fig. 9(a). Shows ~2mm of the implant was embedded into the bone tissue. There was also new bone 
formation seen around apical area of the implant. (b) the height of the alveolar bone on the palatal side 
was significantly lower than the buccal side (*p<0.05). (Bar=1mm). 
 
 
 
 
 
 
 
Fig. 10(a). Shows the implant position was located slightly in platal side. (b) shows the correct 
position and the improved result (c) (bar=1mm). 
 
5.5 Discussion 
The rat is a widely used animal in dental research [26-28, 37]. The jaw bones have been 
used to model many human orofacial clinical situations, such as periodontitis [38], 
orthodontic tooth movement [39], periodontal regeneration [40], and the relationship between 
systemic diseases (e.g. osteoporosis [41] and diabetes [38]) with periodontal disease.  
However, there is inadequate published literature describing the use of the rat maxillary bone 
in dental implant research. The recent consensus statement from the Eighth European 
workshop on preclinical in vivo research (ARRIVE guidelines) concluded rodents were 
primarily used for osseointegration research when examining the effects of systemic disease. 
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When healthy animals were used, the predominant implant sites were extra-oral, i.e. tibia and 
femur [42].   
There are two pre-clinical studies that specifically recommend the use of the rat maxilla 
as acceptable implant placement sites for dental implant research. Kavanagh et al. (1985) 
used a specially designed implant placed into the extraction socket of the second maxillary 
molar. A splint was then used to keep the implant stable during the healing phase. In a later 
study, Karimbux et al. (1995) placed a 1 x 2mm implant into the maxilla without extracting 
the molars. Both of these studies raised the issue of the difficulties associated with the 
surgical procedures and subsequent histological preparation and analysis. However both 
recommended the use of the maxilla as a useful site for implant placement. The methodology 
proposed in these studies however is of limited value today given recent developments in 
both implant technology and histological analysis using resin-embedded sections. Another 
dilemma for researchers is the selection of the ideal implant position as these two studies 
used different implant placement positions within the maxillary alveolar bone. Kavanagh et 
al. (1985) recommended using the second maxillary molar site following extraction whilst 
Karimbux et al. (1995) used a site anterior to the first molar. Interestingly, a majority of 
subsequent pre-clinical studies that used the maxilla, chose to select the first molar site rather 
than either of the positions recommended by the above authors [14, 15, 21-27, 29-35].  
Furthermore, most of those studies also omitted to report a detailed methodology and/or 
histological and histomorphometric analysis.  
Long bones such as the femur have been the most commonly utilized site for dental 
implant research due to their relatively easier surgical access compared to the oral cavity. 
However there are several issues with the use of long bone as a research tool for the study of 
dental implant osseointegration. It is impossible to simulate the oral environment in the long 
bone model and hence it is difficult to extrapolate the results to clinical situations. There are 
also multiple common oral environmental factors that cannot be simulated in the long bone 
model such as masticatory function, interactions with oral bacteria and the effects of saliva, 
which may have important influences on osseous healing and the osseointegration process.  
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Perhaps more importantly, there are fundamental differences in the bone tissues 
themselves in relation to developmental origin and ossification mechanism. Embryologically, 
long bones arise from the mesoderm whereas the craniofacial bones arise from the 
neuroectoderm [43]. The ossification mechanism (intramembranous for maxilla compared to 
endochondral for long bones) and response to hormones are also different between these two 
types of bones and it is believed that craniofacial bones are less sensitive to hormonal 
changes than the extra-cranial skeleton [44].  For example, studies that have used animal long 
bones have showed that osteoporosis negatively influenced osseointegration. However 
similar studies when repeated in alveolar bone found that there was no effect on 
osseointegration [32, 45]. Furthermore, evidence has shown that there is a higher mineral 
density and calcium concentration in intramembranous bones compared with long bones in 
both humans and animals [46-48] along with bone matrix compositional differences [49]. It is 
also noteworthy that the morphology of osteocytes found in intramembranous bones is 
significantly different from that of long bones, being more round in shape [50]. These may 
reflect inherent genetic and/or epigenetic differences between bones of craniofacial and non-
cranial origin [51]. On the whole, this evidence suggests that a craniofacial alternative to 
using long-bones in the rat as a model for dental implant osseointegration research is 
warranted. 
The morphological and micro-CT analysis in the present study demonstrated that the 
anatomy of the rat maxilla is relatively complex. The mesial root of the first molar was 
determined to be the most suitable site for dental implant placement. However the two 
fenestrations in the palate located oblique to the front of the first molar result in significantly 
thinner bone on the palatal side compared to the buccal side. Hence, when preparing the 
implant socket, the drill position should be slightly more towards the buccal than the palatal 
side, as indicated by the yellow circle in figure 5d. 
The decision to use a 3mm long implant in this study was based on the dimensions of the 
mesial root of the first molar obtained from the preliminary morphometric analyses (Fig 3.). 
While the post-surgical histology results often showed that the sinus was penetrated by the 
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apical aspect of the implant, the implant placement protocol necessitates the engagement of 
the cortical plate of the sinus floor in order to achieve primary stability. Thus, we suggest that 
the osteotomy position and angulation should be more towards the buccal bone, at least 
0.5mm away from the mesial root extraction socket, rather than just following the direction 
of the extraction socket (Fig. 5d and Fig. 10). Also a shorter implant is recommended which 
would engage more with the buccal bone, decreasing the incidence of sinus perforation. 
Fracturing of the tooth roots was a common observation. If the implant is placed in 
contact with the remaining roots, there is a significant possibility of forming an encapsulation 
from the PDL thus reducing the degree of osseointegration. However we found the distance 
between the distal roots and mesial root (on average ~ 2 mm) makes this an unlikely event 
(Fig. 3).   
The percentage of bone to implant contact (%BIC) is routinely used to quantitate 
osseointegration. However, a variety of methods have been used to assess bone to implant 
contact [52-54]  and the methodology used to measure this key parameter is variable [15, 24, 
29]. While the implant used in this study is slightly longer than the available alveolar bone 
height, by only assessing implant contact with the adjacent native bone, this will exclude any 
bone formation associated with the sinus perforation (Fig. 2).  
There are many factors to consider when selecting an appropriate animal model for 
dental implant research. Most previous animal studies have used larger animals such as the 
pig, dog, sheep and even primates [55-59]. The advantages for these models includes a 
similarity in bone composition and bone density [60], as well as similar bone remodeling and 
bone turnover compared with humans [61-65]. Beside these, another clear advantage of such 
animal models is the similar size of the jaw-bones compared with humans, thus permitting 
the use of commercially available implants. This infers that the results obtained are more 
likely to mimic those expected in humans.  
However, larger animals are usually more expensive, require larger and more 
sophisticated animal facilities, and have a higher maintenance cost, which partly inhibits their 
availability for research. In comparison, smaller animals will always be more cost-effective, 
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easier to house and handle [10] and allow easy chronological observation and larger samples 
numbers [66]. In the case of rats, an additional advantage is the ability to readily simulate 
various systemic diseases that could influence bone quality and osseous healing processes 
such as osteoporosis [10, 42, 53] Importantly, it has been demonstrated that rats have very 
similar trabecular bone remodeling to that in humans [67]. 
The demonstration of similar results to those seen with larger animals would therefore 
indicate that the rat maxilla is indeed a good model for dental implant research.  The 
histological results of this study show that the first molar maxillary site allows for customized 
implants to be embedded approximately 2mm into alveolar bone. By day 7 of healing, there 
was clearly new bone formation around the implant with significant osteoblast and osteoclast 
activity, which is in agreement with previous studies [31]. New bone formation continued to 
form until day 28 after which there were no further significant increases in either the 
percentage BIC or BA. Previous studies in a primate model, demonstrated a similar level of 
BIC at 67.3% in the maxilla following the establishment of osseointegration after nine 
months [58]. Considering the differences in metabolic rates [68], 28 days of healing in rats 
approximately correlates with the results obtained in primates after 1 year. This is additional 
evidence supporting the proposed maxillary site in the rat as an alternative model for dental 
implant research. 
 
5.6 Conclusion  
We found the mesial root socket of the first molar in the rat maxilla is auseful model for 
dental implant research.  28 days of healing can be considered as an appropriate end point to 
assess the degree of osseointegration as measured by percentage bone-to-implant contact 
(%BIC) and bone area (%BA). The recommended implant dimensions for this particular site 
in the rat is 1.5mm in width and 2mm in length. 
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6.1 Abstract 
Background: Osteocytes, the most abundant cells in bone, have multiple 
functions including acting as mechanosensors and regulating mineralization. It is 
clear that osteocytes influence bone remodeling by controlling the differentiation 
and activity of osteoblasts and osteoclasts. Determining the relationship(s) between 
titanium implants and osteocytes may therefore benefit our understanding of the 
process of osseointegration.  
Purpose: The aim of this study was to visualize the ultrastructural relationship 
between osteocytes and the titanium implant surface following osseointegration in 
vivo. 
Materials and Methods: Titanium implants were placed in the maxillary molar 
region of eight female Sprague Dawley rats, aged 3 months old. The animals were 
sacrificed 8 weeks after implantation and undecalcified tissue sections were 
prepared. Resin-cast samples were subsequently acid-etched with 37% phosphoric 
acid prior to examination using scanning electron microscopy (SEM).  
Results: Compared with mature bone where the osteocytes were arranged in an 
ordered fashion, the osteocytes appeared less organized in the newly formed bone 
around the titanium implant. Further, a layer of mineralization with less organic 
components was observed on the implant surface. This study has shown for the first 
time that osteocytes and their dendrites were directly connected with the implant 
surface.  
Conclusions: This study shows the direct anchorage of osteocytes via dendritic 
processes to a titanium implant surface in vivo. This suggests an important 
regulatory role for osteocytes and their lacunar–canalicular network in maintaining 
long term osseointegration. 
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 6.2 Background 
Osteocytes embedded in bone tissue are the longest-lived and most abundant 
cell type in adult bone, comprising 90~95% of all bone cells. [1] These cells arise 
from matrix-producing osteoblasts passively embedded in the osteoid/matrix 
produced by neighboring cells. [2] Recently, mounting evidence supports a 
prominent and multi-factorial role for osteocytes in bone homeostasis. They may act 
as a mechanosensor perceiving strain signals and developing micro-cracks through 
their cell body, dendritic processes or the bending of cilia. [3, 4] [5] They may also 
react to hormonal changes such as estrogen deficiency, which through an increase in 
osteocyte apoptosis, triggers bone remodeling and resorption. [6]  Osteocytes may 
also play a role in mineral (phosphate) regulation and biomineralizaton via the 
action of osteocyte-specific proteins such as PHEX, DMP-1, MEPE, and FGF-23. [7]  
It has also been shown that osteocytes play a very important role in bone remodeling 
through the actions of the Wnt/β-catenin pathway regulators Dkk1 and sclerostin, 
both of which are highly expressed in osteocytes.
6
 Previously thought of as a 
“passive placeholder in bone”, [8]  it’s now being increasingly acknowledged that 
the osteocyte plays a key regulatory role in osteoclast and osteoblast activity and 
mineral metabolism. 
 
The dental implant has become a popular and predictable technique for 
replacing missing teeth. This treatment relies on the process of osseointegration 
whereby the titanium is bound to bone tissue without any intervening soft tissue. [9]  
However the biological mechanisms responsible have not been fully elucidated, 
especially with regard to the possible role of osteocytes in the maintenance of 
osseointegration. [10]  Moreover, the relationship of osteoblasts/osteocytes with the 
implant surface and the ultrastructural details of the bone-implant interface are not 
fully understood. The ‘gold-standard’ for evaluating osseointegration is histological 
staining and observation using light microscopy (LM), [11]  whereby non-
The ultrastructure of osteocytes on osseointegration  Page 94 
 
decalcified ground sections of resin embedded samples are used to measure the bone 
contact ratio (BCR) or bone-implant-contact (BIC). [12]  Scanning electron 
microscopy (SEM) in the backscatter electron emission (BSE) mode can also be 
used for the measurement of BCR/BIC to examine the early implant-bone healing 
process in vivo. However, one of the limitations of the LM and BSE-SEM methods 
is the inability to identify different types of bone cells in vivo. Transmission electron 
microscopy (TEM) is a better way to visualize the cells around the implant, but this 
technique can only examine the interface without the implant being present, and 
only allows observation in two dimensions within a very small area. Therefore, a 
method which can visualize the ultrastructure of the implant-bone interface in three-
dimensions (3D) would be beneficial in facilitating the study of the relationship 
between bone cells and the implant surface. 
 
Resin-cast methods utilizing acid etching were originally used to investigate the 
3D structure of osteocytes and their lacunar–canalicular network (LCN) at the outer 
border of fractured bone samples. [13-15].  Historically, fracture techniques 
combined with an acid etching protocol do not always adequately maintain the 
integrity of osteocytes and their LCN structure. More recently, Feng et al. used a 37% 
phosphoric acid etching treatment on the surface of bone tissue embedded in MMA 
(methyl methacrylate) to acquire a clear 3D SEM image of osteocytes with their 
LCN structure. [16] This approach provides a novel method to study the delicate 
and complex ultrastructure of osteocytes and their associated LCN within bone 
tissue. Since osseointegrated dental implants are in direct contact with bone without 
any intervening soft tissue, examination of osseointegrated implant samples using 
the acid-etched resin-cast implant can be used to better understand the implant-bone 
interface. 
In vitro studies have shown that osteoblasts attach to implant surfaces where 
they secrete osteoid onto the surface.[17, 18]  As osteocytes are the terminal cells of 
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osteoblasts, we hypothesise that osteocytes may remain in close contact with the 
implant surface during osseointegration, where they are then able to play an 
important regulatory role in the modeling and remodeling processes of 
osseointegration. The aim of this study therefore was to investigate the feasibility of 
using the resin-cast osteocyte method to observe the relationship between the LCN 
(including osteocytes) structure and the implant surface at the ultrastructural level in 
osseointegrated implant samples. 
 
6.3 Materials and methods 
Animals. 
Eight 3-month-old female Sprague-Dawley rats, weighing approximately 265–
300g, were obtained from the Shanghai animal resource center (SLAC Laboratory 
Animal Co. Ltd, Shanghai, China).  The Animal Care and Use Committee of Fujian 
Medical University approved the animal research protocol. The protocols used are 
similar to previously published research. [19]  
 Implants and Implant placement 
Screw shaped micro-rough surface modified implants (2 mm in diameter x 3 
mm long, Ra=1.55μm) were obtained from Southern Dental Implants (Irene, South 
Africa). Implant placement was performed under general anesthesia. Briefly, one 
maxillary first molar was extracted from each animal followed by immediate 
insertion of the implant into the freshly extracted socket. The animals were 
sacrificed at 8 weeks using an overdose of ketamine. 
Resin Embedding and Acid-Etching 
The non-decalcified maxillae containing the implants were fixed in 4% neutral 
formalin for 48 hours. The specimens were dehydrated in a series of graded alcohols 
and were embedded using Technovit 7200 resin. Ground sections of the calcified 
samples were prepared as previously described. [19]  Briefly, the specimens were 
sectioned using a diamond saw (Exakt-Trennschleifsystem 300CP, EXAKT
®
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Apparatebau GmbH &Co KG, Norderstedt, Germany) at two points equidistant 
from the middle and perpendicular to the long axis of the implants. One of the 
sections was ground to a 30 µm thickness for histological assessment, while the 
other section was first ground using 1200 grit sandpaper and then polished with 
diamond suspensions (6, 1, and 0.25 μm particle size) and prepared for the resin-cast 
osteocyte technique as previously described. [16]  Briefly, the surface of the 
polished sections was first acid etched with 37% phosphoric acid for 10 seconds 
then immersed in 5% sodium hypochlorite for 5 min and air-dried overnight. The 
sections were coated with gold and examined using a Carl Zeiss SIGMA VP field 
emission scanning microscope (FE-SEM; Carl Zeiss. SMT GmBH, Oberkochen, 
Germany) operated at a voltage of 15 or 20 kV. The focus of the ultrastructural 
analysis was the interface between bone and the implant surface. Elemental analysis 
was performed using the polished samples coated with gold with the same scanning 
microscope. 
 
 6.4 Results  
Under light microscopy, histological images showed that most of the implant 
surface was covered with new bone lamella that was connected to the pre-existing 
bone by newly formed trabecular bone (Fig.1a) There was no observable gap 
between the implant and bone, even under high magnification. Multiple osteocytes 
could be seen in the new bone surrounding the implants although it was difficult to 
visualize the LCN structure (Fig.1b)  
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Figure 1. (a) Bone-implant interface. (b) At higher magnification, there is no visible gap 
between the bone tissue and implant surface. Dotted line shows the border of new bone and old 
bone. In the newly formed bone area, osteocytes with nuclei can be observed. 
 
BSE-SEM observation under low magnification also showed the bone to be in 
close proximity to the implant surface, with no gap evident between the implant and 
bone tissue at the interface (Fig.2a). This is consistent with the light microscopy 
observations. However, under higher magnification a small gap of approximately 2-
2.5 µm is evident in some areas at the interface between the implant and bone 
(Fig.2b). This is most likely a result of resin shrinkage during polymerization 
resulting in a fracture between the implant and the bone tissue. 
 
 
 
 
 
 
 
 
Figure 2. Backscatter image of an osseointegration using SEM. (a) Under low 
magnification, the histological image shares many similarities to those of the light microscopy, 
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where bone is in close contact to the implant surface. (b) Under higher magnification, there is a 
2-2.5 µm gap seen between the implant and bone interface in some areas. This gap as a result of 
processing however was inconsistent as in some areas there was no shrinkage observed. 
 
Following acid-etching of the undecalcified specimens, under low SEM 
magnification it was apparent that most of the calcified component of the bone 
matrix had been removed leaving the osteocytes exposed. It was observed that the 
osteocytes were arranged in an orderly manner in the bone distant to the implant. 
This bone is likely to be mature tissue that was not involved in the healing process 
associated with implant placement and osseointegration. However, new osteocytes 
located adjacent to the implant appear to have a disorderly arrangement (Fig.3a&b). 
There are more osteocytes in the newly formed bone areas compared with the old 
trabecular bone, especially in the area surrounding the implant thread
（Fig.3a&3c）. The residual irregular, intact tissue apparent in the images is likely 
to be non-mineralized matrix, vessels or marrow cavities which were not affected by 
the acid-etching process (Fig.3a).  
 
 
 
 
 
 
 
Figure 3. Low SEM magnification shows the outline of bone tissue. Note that osteocytes in 
old bone area appear well-ordered (a) red dotted line shows the border of old bone and new 
bone; yellow dotted line shows osteocytes with orderded arrangement) compared with 
osteocytes in new bone area (thread area). The irregular, intact tissue includes non-mineralized 
matrix, vessels (red box show vessels in the bone tissue) and bone marrow cavities (BM). (b) 
shows the unordered osteocytes between threads (arrows indicate osteocytes). Cells become 
disorganized in the newly formed bone, especially between the threads. (c) Compared with the 
old bone area,  average osteocyte numbers (Avg OS.N) were significantly higher in the new 
bone areas (p<0.05). 
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Under higher magnification, the osteocytes and the associated LCN could be 
clearly visualized around the implant (Fig.4). Osteocytes were situated in the cavity 
of their lacunae, which is evident as a relatively dark area after the acid-etching 
process. Osteocytes were connected with each other via a dendritic network with 
branches extending deep into the canalicular structure, presumably connecting with 
osteocytes distant to the implant. For the first time, this study has shown that the 
interwined dendrites from osteocytes are also directly in contact with the implant 
surface (Fig.5). In addition to the intecelluar connection between osteocytes via their 
cell processes, they were also connected with bone marrow through their dendrites 
(Fig 3). Interestingly, following the acid-etching process there were many 
discontinuous alternating regions of an undecalcified substance and dark areas that 
ran parallel the implant surface (Fig 6). While most of the osteocytes were situated 
beside this dark area, this region however was not totally devoid of osteocytes 
(Fig.7). This ‘dark area’ could be interpreted to mean that the implant was 
surrounded by a sparse, poorly calcified area which was easily removed by acid-
etching. This hypothesis is supported by the SEM elemental scanning analysis, 
which showed that this area, nearly 6-7 μm wide, had gradually decreasing levels of 
calcium and phosphate ions as it approaches the implant surface (Fig.8). 
 
 
 
 
 
 
 
 
Figure 4. Osteocyte situated in lacuna with its dendrites connected to others, forming LCN 
structure. (Right image is an amplified osteocyte image of the left box in right image). 
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Figure 5. Osteocyte (red arrow)with its dendrites in direct contact with implant surface 
(Right image is the amplified image of the box in left image). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. (a) low magnification shows alternating regions of an un-decalcified substance 
(yellow arrows) and dark gaps (orange arrows) alongside implant. (b) Higher magnification 
shows most of the osteocytes (red arrows) were shown to be alongside the dark gap adjacent to 
the implant after the acid-etching process. 
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Figure 7. (a) High magnification image shows osteocytes (red arrows) situated in the ‘dark 
area’ as described in Fig 6, that are in direct contact with implant. (b)In the alternate 
undecalcified substance areas as described in Fig 6, osteocytes (red arrows) were shown to be 
attached to the implant surface via this thin undecalcified substance (between yellow dashed 
lines) which is directly in contact with the implant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. SEM/Energy-dispersive spectrometer (SEM/EDS) elemental analysis of the 
mineralised tissue. (a) Shows the line scan position in relation to the implant (yellow line). (b) 
High magnification of the elemental line scan (~40 μm). (c) The Ca and P ion concentrations 
gradually decreased over a distance of 6-7 μm (red bars) towards the implant surface. This 6-7 
μm area corresponds to the previously described ‘dark area’. 
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Figure. 9 Diagram (a) shows the implant embedded in bone tissue (blue zone) that consists 
of lower density mineralized tissue which represents the dark areas alternating with 
undecalcified substance). The dendrites derived from osteocytes are intertwined with the 
implant to reinforce osseointegration. The advantage of this type of structure is that it allows 
the distribution of masticatory forces and micro-movement of the implant. This zone acts like a 
cushion similar to that of the natural periodontal structure (b).  (c) Enlarged diagram of area 
adjacent to implant (red box). Blue spots represent Ca ions and green spots represent P ions. 
Because of the sparse and poor mineralization and less organic tissue near the interface under 
acid-etching conditions, mineralized substance is removed quickly producing a relative dark 
area. 
6.5 Discussion 
Using a novel acid-etching methodology combined with SEM imaging, this 
study confirmed the hypothesis that osteocytes maintain close contact with the 
implant surface during osseointegration, demonstrated by the ultrastructural 
observation of osteocyte dendritic structures in direct contact with the implant 
surface.  
Few studies have examined the relationship between osteocytes and the dental 
implant surface.[20, 21]
 
 Using classical histological observation, previous reports 
have focused on changes in osteocyte density around the dental implant to infer the 
role of osteocytes in osseointegration. Until now, little information has been 
published regarding the ultrastructural relationship between osteocytes and dental 
implants. 
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The most frequently used methods for analyzing the interface between cells 
(including osteocytes and their LCN structure) and/or tissues and implants following 
osseointegration have been traditional histology methods using light microscopy or 
scanning electron microscopy in the backscattered electron mode.[22]  In order to 
examine the interface between bone tissue and the implant, it is preferable for the 
sections to include both the implant and bone tissue. To achieve this with current 
technologies, samples need to be embedded in resin, cut using a diamond saw and 
ground until the sections’ thickness is between 15-50μm. The histological sections 
used in this study were approximately 30μm thick and showed similar 
characteristics to other reported studies, [23, 24]
 
 i.e. the host bone was in close-knit 
contact with the implant when viewed at both low and high magnification. 
Unfortunately, given the thickness of the sections, it was difficult to visualize 
osteocytes, much less their LCN structure. Indeed, even with conventional paraffin 
embedded 5μm thick tissue sections, other reported studies have also shown that it is 
difficult to visualize the delicate LCN structure. [22]  Using the BSE-SEM method, 
close contact between bone tissue and the implant surface was observed at lower 
magnifications. At higher magnifications, some areas exhibited a 2-2.5µm gap, 
which was most likely an artifact caused by shrinkage during the resin 
polymerization process. Notably, neither of these routine methods can differentiate 
the 3D ultrastructure of osteocytes around osseointegrated implants.  
Bone has a hierarchical structure at both the microscopic and macroscopic level, 
which allows it to perform its primary function of providing support and distributing 
biomechanical load. After treating the samples with the acid-etching protocol, it was 
shown that the osteocytes situated in the resident bone away from the implant were 
arranged in an orderly fashion, which is indicative of adaptation to mechanical 
loading. However, within the newly formed bone adjacent to the implant, osteocytes 
appeared to have a disorderly arrangement. One possible explanation for this 
observation is that the newly formed bone lacks functional adaption as it is yet to 
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undergo remodeling in response to loading stimuli. The different appearance of the 
osteocyte arrangement between mature and newly formed bone implies that 
osteocytes around implants may change orientation once exposed to the appropriate 
stimuli. However, further ultarstructural studies of osteocyste orientation around 
loaded implants are required to confirm this hypothesis.  
There were also relatively more osteocytes in the newly formed bone, especially 
within the implant thread area, when compared with the original trabecular bone. 
This is consistent with a previous report which examined the relationship between 
osteocytes and implants.[21]
   
In that study, a higher osteocyte density was observed 
near the implant after a relatively short time span (1-5years) following surgery, 
which subsequently decreased with increasing time (14-27years). In this respect, 
clearly one of the limitations of the present study is the use of a single time-point for 
investigation (8 weeks) as it is then impossible to predict any temporal changes in 
osteocyte numbers/density or morphology over longer periods of bone modeling and 
remodeling. As osseointegration is a dynamic process, it would be interesting to use 
the methodology described in this study to examine the temporal changes in 
osteocytes and their relationship with the implant surface. 
Osteoblasts/osteocytes play a key role in the establishment and maintenance of 
osseointegration. Osteocytes residing in the lacuna, representing the terminally 
differentiated cell of the osteoblast lineage, were seen to be interconnected with 
each other by means of their dendritic cell processes. This network, named the 
lacuno-canalicular network (LCN),[25] is known to play a vital role in nutrient 
transport, cellular communication[26] and mineralization. The osteocyte LCN 
structure has been shown to have the ability to sense mechanical strain, and regulate 
adaptive responses by coordinating the bone-remodeling processes. [27, 28]
 
 Taken 
in the context of the contemporary literature about the function of oseteocytes,[8, 29]
 
the observations reported in this study, suggest that osteocytes situated in the LCN 
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network regulate the dynamic bone metabolic processes that are necessary for 
maintaining long-term successful osseointegration. 
According to the concept of osseointegration, the titanium implant is in direct 
contact with host bone. In previous in vitro models, it was noted that there was a 
layer of protein matrix between osteoblasts and the implant surface.[17, 18]
 
 
However, due to methodological limitations, there has been a lack of definitive 
evidence in vivo to support the notion that oeteoblasts/osteocytes come in direct 
contact with the implant surface.  
Using a novel acid-etching method together with SEM imaging, this study 
clearly shows that osteocyte dendrite structures are in direct contact with the implant 
surface. This not only provides a deeper understanding of the osseointegration 
process, but also new opportunities to investigate the relationship between 
osteocytes and implants in health and disease. The results of the study suggest that 
during the early stages of bone formation, osteoblasts establish contact with the 
implant surface and maintain this relationship until they differentiate into osteocytes 
and become embedded in the mineralized matrix. Subsequently, the osteocytes 
utilise their dendrites to maintain direct contact with the implant and the LCN 
network, thus ensuring adequate nutritional supply and facilitating mechanosensing 
in the local microenvironment. 
The response of bone tissue to dental implants depends on many factors 
including the implant surface, the time at which the sample was evaluated, the 
recipient site and the animal species used. Using a rat maxilla model similar to that 
used in the present study, Futami et al (2000)[30]
  
showed that the establishment of 
osseointegration (at the light microscope level) occurred considerably earlier 
(4weeks post-implantation) than that reported in other studies (6-12 weeks post-
implantation) which used endochondral recipient bones such as the femur, tibia and 
fibula.[31, 32]  Therefore the eight-week healing time-point used in the present 
study suggests that the observed ultrastructural arrangement of the osteocytes and 
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their LCN may be representative of new bone that has undergone a period of 
remodeling.  
Irrespective of whether osseointegration occurs via distance’ or ‘contact’ 
osyteogenesis [33], given that the maxilla develops by intramembraneous 
ossification, it is not surprising that intramembraneous rather than endochondral 
ossification occurs around dental implants placed in the rat maxilla. In vivo studies 
in both animals and humans have demonstrated that the implant surface topography 
and or chemistry can also affect both the rate and degree of osseointegration.[23, 34]. 
While this study used a moderately rough titanium implant surface That is likely to 
favour ‘contact’ osteogenesis, whether surface characteristics that increase the 
degree of roughness at the micro and/or nano-scale would also influence the 
osteocyte- LCN morphology and/or the arrangement around the implant surface is 
unknown and requires further investigation. 
Interestingly, many relatively dark areas were noted at the implant interface 
with alternating areas of a thin undecalcified substance. These dark areas 
approximately 6 - 7µm wide were not the same as the shrinkage gap following 
processing that varied in size up to a maximum distance of only 2-2.5µm wide. 
Given that the purpose of using the acid-etching protocol is to remove the 
mineralized tissue and keep non-mineralized and organic tissue intact, a dark area 
usually means that more mineralized tissue has been removed. However, in the time 
allotted for the acid etching process, this phenomenon presumably would only 
happen in a relative sparse and less mineralized tissue with a higher organic 
component. Using SEM elemental analysis these areas were indeed less mineralized, 
as the density of calcium and phosphorous ions gradually decreased as it approached 
the implant surface over an area that was nearly 6-7μm in length. The dark area also 
may be a reflection of increased metabolism in the microenvironment around the 
implant. In addition to the dark areas representing reduced mineralization, 
undecalcified areas were also shown to exist around the implant. In these areas, 
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osteocyte contact with the implant surface was via a thin undecalcified substance. 
This is consistent with previous studies that have reported a thin undecalcified 
substance consisting of three different layers. The first is a 20-50nm collagen-free 
zone, followed by a 100-500nm zone of randomly distributed collagen fibers in 
which osteocytes were occasionally found. The third layer consisted of collagen 
fibers oriented in orderly bundles.[35] 
Many other previous studies have also reported the presence of an intervening 
layer containing cellular elements and/or amorphous substances at the bone-implant 
interface. This non-mineralised amorphous layer on the implant surface most likely 
represents interposed cells that have been compressed and degenerated by either 
space constrictions, nutrient deficiency and/or compaction by new bone deposition 
during the remodeling process.[33, 36]  While the function of this layer is as yet 
unresolved, the large number of fibroblast-like cells, multinucleated giant cells and 
macrophages present suggests it may ultimately serve as a means to make space for 
new bone formation. 
The results of this study suggest that the implant is embedded in a bone tissue 
matrix consisting of both areas of decreased mineralization where osteocytes are in 
direct contact with the surface, and thin zones of undecalcified substance through 
which the osteocytes connect to the implant surface via dendritic processes. This 
structure may partly replicate the periodontal ligament microenvironment and 
proprioceptory function around natural teeth (Fig.9), albeit to a lesser extent, 
whereby the osteocyte dendritic processes provide a cushion around the implant that 
not only allows for small elastic micro-movements that are advantageous for the 
distribution of masticatory forces, but also provides a potential mechanism for 
osseoperception.  
A further consideration regarding the process of osseointegration is the timing 
of implant placement following tooth extraction. From a number of systematic 
reviews of the literature, there is currently insufficient evidence that either 
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immediate or delayed implant placement results in improved osseointegration in the 
long term.[37, 38]  The healing mechanism of the bone tissue may be expected to be 
the same regardless of the implant placement timing protocol, especially when there 
is an absence of a gap between the implant and the edges of the extraction socket, as 
was the case in this study. Therefore, it is unlikely that that the osteocyte-LCN 
morphology would be significantly affected by the implant placement timing, 
although this needs to be confirmed in additional studies. 
 
 6.6 Conclusions 
Resin-casting of samples containing metallic implants and bone followed by 
phosphoric acid etching is an effective technique for visualizing the ultrastructure of 
osteocytes and the LCN around osseointegrated implants using SEM. Visualisation 
of the nature of the interaction of osteocyte dendrites with the implant surface 
allows us to better understand the ultrastructure of osseointegration and the micro-
dynamic metabolic processes associated with implants in host bone. The finding of a 
low-density mineralized zone immediately adjacent to the implant along with 
osteocyte dendritic processes contacting the implant surface may explain the 
biomechanical mechanism through which implants can adapt to changing 
masticatory forces and thereby support prostheses for long periods of time. This 
study suggests that the osteocyte-LCN structure is likely to play an important role in 
maintaining the dynamic metabolic microenvironment around implants, with 
osteocytes having a vital role in maintaining successful long-term osseointegration. 
 
 
 
 
 
 
The ultrastructure of osteocytes on osseointegration  Page 109 
 
 6.7 References 
1. Boskey, A.L. and R. Coleman, Aging and bone. J Dent Res, 2010. 89(12): p. 
1333-48. 
2. Franz-Odendaal TA, H.B., Witten PE., Buried alive: how osteoblasts 
become osteocytes. Dev Dyn, 2006 Jan. 235(1): p. 176-90. 
3. Bonewald, L.F., Mechanosensation and Transduction in Osteocytes. 
Bonekey Osteovision, 2006. 3(10): p. 7-15. 
4. Klein-Nulend, J., et al., Mechanosensation and transduction in osteocytes. 
Bone, 2012. 
5. Malone, A.M., et al., Primary cilia mediate mechanosensing in bone cells by 
a calcium-independent mechanism. Proc Natl Acad Sci U S A, 2007. 
104(33): p. 13325-30. 
6. Khosla, S., M.J. Oursler, and D.G. Monroe, Estrogen and the skeleton. 
Trends Endocrinol Metab, 2012. 23(11): p. 576-81. 
7. LF, B., Osteocytes as dynamic multifunctional cells. Ann N Y Acad Sci. , 
2007  Nov;1116: p. 281-90. 
8. Bonewald, L.F., The amazing osteocyte. J Bone Miner Res, 2011. 26(2): p. 
229-38. 
9. Brånemark, P.I., Osseointegration and its experimental studies. J Prosthet 
Dent, 1983a. 50: p. 399-410. 
10. Joos U, W.H., Szuwart T, Meyer U., Mineralization at the interface of 
implants. Int J Oral Maxillofac Surg., 2006. 35(9): p. 783-790. 
11. L.SENNERBY, P.T., L.E.ERICSON, Ultrastructure of the bone-titanium 
interface in rabbits. JOURNAL OF MATERIALS SCIENCE:MATERIALS 
IN MEDICINE 3, 1992: p. 262-271. 
12. Koh, J.W., et al., Biomechanical evaluation of dental implants with different 
surfaces: Removal torque and resonance frequency analysis in rabbits. J 
Adv Prosthodont, 2009. 1(2): p. 107-12. 
13. Abe K, H.H., Ushiki T., An EDTA-KOH method to expose bone cells for 
scanning electron microscopy. . J Electron Microsc 1992. 41: p. 113-115. 
14. Ejiri S, O.H., Scanning electron microscopic observations of rat tibia using 
the HCl-collagenase method.  
. Arch Histol Jpn, 1982. 45: p. 399-404. 
15. Curtis TA, A.S., Weber DF. , Canalicular communication in the cortices of 
human long bones.  . Anat Rec, 1985. 212: p. 336-344. 
16. Feng, J.Q., et al., Loss of DMP1 causes rickets and osteomalacia and 
identifies a role for osteocytes in mineral metabolism. Nat Genet, 2006. 
38(11): p. 1310-5. 
17. Sammons, R.L., et al., Comparison of osteoblast spreading on 
microstructured dental implant surfaces and cell behaviour in an explant 
The ultrastructure of osteocytes on osseointegration  Page 110 
 
model of osseointegration. A scanning electron microscopic study. Clin Oral 
Implants Res, 2005. 16(6): p. 657-66. 
18. Meyer, U., et al., Basic reactions of osteoblasts on structured material 
surfaces. Eur Cell Mater, 2005. 9: p. 39-49. 
19. Du, Z., et al., Effects of Simvastatin on bone healing around titanium 
implants in osteoporotic rats. Clin Oral Implants Res, 2009. 20(2): p. 145-50. 
20. Barros, R.R., et al., Osteocyte density in the peri-implant bone of 
immediately loaded and submerged dental implants. Journal of 
periodontology, 2009. 80(3): p. 499-504. 
21. Piattelli, A., et al., Osteocyte density in the peri‐implant bone of implants 
retrieved after different time periods (4 weeks to 27 years). Journal of 
Biomedical Materials Research Part B: Applied Biomaterials, 2014. 102(2): 
p. 239-243. 
22. Kubek DJ, G.V.n., Allen MR., Methodological assessment of acid-etching 
for visualizing the osteocyte lacunar-canalicular networks using scanning 
electron microscopy. Microsc Res Tech., 2010. 73(3): p. 182-6. 
23. Lang, N.P., et al., Early osseointegration to hydrophilic and hydrophobic 
implant surfaces in humans. Clinical Oral Implants Research, 2011. 22(4): p. 
349-356. 
24. Bosshardt, D.D., et al., The role of bone debris in early healing adjacent to 
hydrophilic and hydrophobic implant surfaces in man. Clinical Oral 
Implants Research, 2011. 22(4): p. 357-364. 
25. Schneider, P., et al., Towards quantitative 3D imaging of the osteocyte 
lacuno-canalicular network. Bone, 2010. 47(5): p. 848-58. 
26. Knothe Tate, M.L., et al., The osteocyte. Int J Biochem Cell Biol, 2004. 
36(1): p. 1-8. 
27. Aarden, E.M., E.H. Burger, and P.J. Nijweide, Function of osteocytes in 
bone. J Cell Biochem, 1994. 55(3): p. 287-99. 
28. Bonewald, L.F. and M.L. Johnson, Osteocytes, mechanosensing and Wnt 
signaling. Bone, 2008. 42(4): p. 606-15. 
29. Dallas, S.L., M. Prideaux, and L.F. Bonewald, The Osteocyte: An Endocrine 
Cell and More. Endocr Rev, 2013. 
30. Futami, T., et al., Tissue response to titanium implants in the rat maxilla: 
ultrastructural and histochemical observations of the bone-titanium 
interface. Journal of periodontology, 2000. 71(2): p. 287-98. 
31. Ohtsu, A., et al., A histological investigation on tissue responses to titanium 
implants in cortical bone of the rat femur. J Periodontol, 1997. 68(3): p. 270-
83. 
32. Clokie, C.M. and H. Warshawsky, Morphologic and radioautographic 
studies of bone formation in relation to titanium implants using the rat tibia 
as a model. Int J Oral Maxillofac Implants, 1995. 10(2): p. 155-65. 
The ultrastructure of osteocytes on osseointegration  Page 111 
 
33. Nanci A, M.G., Zalzal S, Clokie CML, Warshawsky H, Mckee MD, Tissue 
response to titanium implants in the rat tibia: Ultrastructural, 
immunocytochemical and lectin-cytochemical characterization of the bone-
titanium interface. Cells Mat, 1994. 4: p. 1. 
34. Bornstein, M.M., et al., Bone apposition around two different sandblasted 
and acid-etched titanium implant surfaces: a histomorphometric study in 
canine mandibles. Clin Oral Implants Res, 2008. 19(3): p. 233-41. 
35. Klinger, M., et al., Proteoglycans at the bone-implant interface. Critical 
Reviews in Oral Biology & Medicine, 1998. 9(4): p. 449-463. 
36. Sennerby, L.T., P; Ericson, L. E Early tissue response to titanium implants 
inserted in rabbit cortical bone Journal of Materials Science: Materials in 
Medicine 1993. 4: p. 494-502. 
37. Quirynen, M., et al., How does the timing of implant placement to extraction 
affect outcome? Int J Oral Maxillofac Implants, 2007. 22 Suppl: p. 203-23. 
38. Esposito, M., et al., Timing of implant placement after tooth extraction: 
immediate, immediate-delayed or delayed implants? A Cochrane systematic 
review. Eur J Oral Implantol, 2010. 3(3): p. 189-205. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Chapter 7: The effects of osteoporosis and 
implant topography on 
osseointegration in the rat maxilla 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The effects of osteoporosis and implant topography on osseointegration in the rat maxilla        Page  113 
 
 
The effects of osteoporosis and implant topography on osseointegration in 
the rat maxilla.  
      
      Zhibin Du
1
, Yin Xiao
1*
, Saeed Hashim
2
, Stephen Hamlet
2
, Saso Ivanovski
2*
  
                                                  (Manuscript prepared) 
 
       Suggested Statement of Contribution of Co-Authors for Thesis by Publication 
Contributors Statement of contribution 
Zhibin Du
 
Involved in the conception and design of the project. 
Performed laboratory experiments and wrote the 
manuscript. 
Yin Xiao
 
Involved in designing the whole project, manuscript 
preparation and reviewing. 
Saeed Hashim Participate PCR work , manuscript preparation and 
reviewing 
Stephen Hamlet Involved in the design of the project, and part 
laboratory work 
Saso Ivanovski Involved in designing the project, manuscript 
preparation and reviewing. 
 
Principal Supervisor Confirmation 
I have sighted email or other correspondence from all co-authors confirming their 
certifying authorship 
 
Prof. Yin Xiao                                            
  Name                  Signature              Date 
 
 
  
 The effects of osteoporosis and implant topography on osseointegration in the rat maxilla        Page  114 
 
7.1 Abstract 
Compromised bone quality and / or healing in diseases such as osteoporosis are 
recognised risk factors for dental implant osseointegration. This study aimed to: 1) examine 
the effects of experimentally induced osteoporosis on implant osseointegration using a novel 
rodent model and 2) whether micro-rough implant surface topography could compensate for 
the any deleterious effects of estrogen deficiency.  
Machined and micro-rough surfaced implants were placed into the first molar mesial root 
socket immediately after tooth extraction in the maxilla of ovariectomised (OVX) and sham-
operated (SHAM) rats.  The rats were sacrificed after 3, 7, 14, and 28 days post-implantation 
and osseointegration of the implant was evaluated by histological, scanning electron 
microscopy (SEM), and quantitative real-time PCR (qPCR) analysis. 
Osseointegration as measured by the percentage of bone to implant contact (%BIC), was 
significantly higher around rough surfaced implants in the OVX animals when compared to 
machined implants in OVX animals at day 14. The %BIC in the OVX rough implant group 
was similar to that seen with both rough and smooth implants in SHAM animals at this time. 
By day 28 however, similar levels of %BIC were found for all test groups. This suggests the 
rough surface stimulated a more rapid osseointegration process in OVX animals.  
To assess the possible molecular mechanism(s) responsible for this accelerated 
osseointegration on the rough surface, the level of gene expression of osteoblast, osteocyte, 
osteoclast and inflammatory markers at day 3 and 7 were examined. At day 3 the rough 
surface implant significantly increased the expression of alkaline phosphatase (ALP), 
osteocalcin (OC), alpha-1 type I collagen (COL1A), receptor activator of nuclear factor 
kappa-B ligand (RANKL), tartrate-resistant acid phosphatase (TRAP) and dentin matrix 
protein 1 (DMP1). By day 7, the expression of the inflammatory markers was lower as 
expected with resolution of the initial inflammation at implant placement. Expression of the 
bone markers increased further overall, although there were few significant differences in the 
levels of expression comparing the rough and machined surfaces at this time. These 
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molecular results correlate with the morphological (histology and SEM) observations at these 
early healing time points. 
In conclusion, osteoporosis was found to reduce the early osseointegration (as measured 
by %BIC) of machined implants. However, the rough surfaced implant appeared to trigger a 
cell response able to compensate for the estrogen deficient conditions resulting in %BIC 
similar to that seen in SHAM animals. Nevertheless, this difference was not maintained as 
there was no significant difference in %BIC between the OVX and SHAM groups regardless 
of implant surface in the long-term (day 28).  
 
Key words:  osteoporosis, rat, maxilla, dental implant, osseointegration. 
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7.2 Background 
Osteoporosis is a chronic disease affecting over 200 million people worldwide [1]. 
Osteoporosis in the elderly, especially postmenopausal women is also significantly correlated 
with tooth loss [2-5]. Lower bone density, poor bone quality and osseous microstructural 
changes, all characteristics of osteoporosis, have been shown to delay the bone healing 
process of fractured bone [6-8]. As endosseous implant healing has a similar mechanism to 
that in bone fracture healing [9], it is reasonable to assume that dental implant healing in 
osteoporosis patients may be negatively affected, however this is still a controversial issue 
[10-12]  
Animal studies have reported a relatively lower rate of osseointegration in an 
osteoporotic environment, however it should be noted that the majority of these studies were 
based on the long bone [13-16] rather than jaw bone [17, 18]. While limited studies in the 
mandible using an ovariectomized (OVX) rat model showed no significant difference in bone 
formation around the implant [17, 19], these results have limited clinical significance, as it is 
the maxilla, especially in the posterior area, of osteoporotic patients where there is a high risk 
of dental implant failure because of its porous trabecular bone [20]. 
Implant design and topography are well-known factors to influence peri-implant tissue 
healing [21]. Most animal studies have shown that rough surfaced titanium implants result in 
superior bone to implant contact compared to machined implants  [22, 23], as well as having 
superior torque removal values [24, 25]. However, there have been no studies showing 
whether these rough surfaced implants are able to compensate for the effects of osteoporosis 
on the implant healing process.  
We have previously shown that the rat maxilla area is a good location to assess the 
effects of osteoporosis on alveolar bone quality [26], as well as for dental implant research 
[27]. In this study, the rat maxilla model was used to determine whether estrogen deficiency 
would affect osseointegration in the posterior maxilla and whether rough surfaced implant 
could partly compensate the negative effects on osseointegration due to osteoporosis.  
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7.3 Material and methods 
Animals 
The experimental protocol for the study was approved by the Griffith University animal 
ethics committee (DOH/01/4/AEC).  Forty-six three-month-old female Sprague-Dawley rats 
(Murdoch, Western Australia) were used for the study. Animals were fed standard rat chow 
and water ad libitum throughout the experiment. After acclimatization for 2 weeks, the rats 
were randomly divided into two groups, sham-operated (SHAM, n=23) and ovariectomised 
(OVX, n=23). Ovariectomy was performed according to previously established methods [14] . 
SHAM group rats were also subjected to the same surgical procedure with an equivalent 
amount of fat tissue removed instead of the ovaries. All the operations were performed under 
isoflurane (1–3%) inhalation anaesthesia. The animals were subsequently allowed to develop 
osteoporosis over three months before implant placement. This period of time has been 
shown to be sufficient to develop osteoporosis in this model [26]. 
Implants 
Minimally-rough ‘machined’ (Ra = 0.74 μm) and rough (Ra = 1.27μm) surfaced titanium 
implants (2 x 3mm) produced from Type IV commercially pure titanium were obtained from 
Southern Implants Ltd (Irene, South Africa). The rough surfaced implant was prepared using 
the same techniques as used for commercially available dental implants (Fig.1). 
 
 
 
 
 
 
 
 
Fig.1  Smooth and moderately-rough surfaced implant images under SEM (a). The roughness of the 
implants as measured by atomic force microscopy (AFM) are 0.74μm for the smooth surface implant (b) 
and 1.27 μm for the moderately-rough surfaced implant (c). 
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Surgical Procedures 
Implant placement surgery was carried out 3 months after ovariectomy according to 
previously published procedures [27]. Briefly, implants were immediately placed into the 
first molar mesial socket after tooth extraction. The osteotomy was prepared using a 1.2mm 
pilot drill and a 1.8mm diameter final drill (Southern Implants, Ltd., Irene, South Africa).  All 
osteotomy procedures were performed with copious saline irrigation. Machined and rough 
surfaced implants were placed into the prepared sockets with a torque of 15-20Ncm until the 
implant coronal plane was at the level of the bone crest. The wound was then sutured with 
resorbable sutures (5/0 Vicryl). Post-operative analgesia (buprenorphine 0.01 - 0.05mg/kg 
and carprofen 4 - 5mg/kg) and antibiotic cover (entrofloxacin 2.5mg/Kg) were administrated 
by intraperitoneal injection immediately after the surgery and continued daily for three days 
post-operatively.  
To assess subsequent new bone formation, fluorescencent dyes; alizarin red S (25mg/kg, 
3 days before sacrifice) and calcein (10mg/kg, 10 days prior to alizarin injection) were given 
intraperitoneally. Animals were sacrificed after 3, 7, 14 and 28 days of healing and samples 
were collected for histological, SEM and qPCR analysis. 
Histological Sample Preparation  
Using a diamond-tipped circular saw, block sections of the maxilla containing the 
implants were collected and immediately fixed with 4% paraformaldehyde for 48h at 4°C. 
The samples were then dehydrated in a graded series of ethanol before embedding in 
methylmetacrylate resin (Technovit® 7200 VLC, Heraeus Kulzer, Dormagen, Germany). 
Thirty-micron thick sections of the maxilla containing the implant were prepared using a 
cutting and grinding system  (EXAKT Apparatebau, Norderstedt, Germany) [28]. The 
sections were stained with methylene blue-alizarin red S and scanned using the Aperio 
ScanScope CS at 40 times magnification (Aperio Technologies Inc., Vista, CA). 
Histomorphometric analysis was carried out using ImageScope software at 4 times 
magnification (Aperio Technologies Inc.). The percentage of bone to implant contact (%BIC) 
is defined as the ratio of the sum of the implant surface in direct contact with new bone tissue 
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and the total length of the implant adjacent to native bone (each side contained at least two 
threads). The new bone area (%BA) is defined as the percentage of mineralized bone tissue 
within the threaded areas of the implant that were adjacent to native bone  [27]. 
Scanning electron microscopy   
The cryo-fracture technique [29], was used to prepare osseointegrated samples for SEM 
observation (Carl Zeiss Sigma VP Oxford Micro-analysis Field Emission Scanning Electron 
Microscopy (FE-SEM), Germany). Samples (n=2 in each group) were fixed in 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer (PH 7.4) containing 0.05% tannic acid for 
at least 48h at 4ºC. The samples were then frozen in liquid nitrogen, followed by the cryo-
fracturing. 
Real Time Quantitative PCR 
After unscrewing the implant from the maxilla, tissue from the implant surface and 
socket wall was collected using small dental curette and immediately immersed into TRIZOL 
reagent (Invitrogen).  Total RNA was subsequently extracted from these samples according 
to the manufacturer’s instructions. M-MuLV Reverse Transcriptase was then used to prepare 
complementary DNA (cDNA) according to the manufacture’s protocols.  
Oligonucleotide primers used to assess osteogenic (alkaline phosphatase (ALP), 
osteocalcin (OC), alpha-1 type I collagen (COL1A)), osteoclast (receptor activator of nuclear 
factor kappa-B ligand (RANKL), tartrate-resistant acid phosphatase (TRAP)), osteocyte 
(dentin matrix protein 1 (DMP1), sclerostin (SOST)) and inflammatory marker gene 
expression (tumor necrosis factor-alpha (TNFα), interleukin-1β (IL-1β)) are described in 
table 1.  Real-time PCR reactions (LightCycler 480 Real-Time PCR System, Roche, USA) 
were run using the following parameters: denaturation at 95˚C for 30 s and 40 cycles of 
amplification (95 ˚C for 10 s and 60 ˚C for 20 s). Quantification of gene expression was 
calculated using the delta Ct method and 90% PCR efficiency (k*1.9Δct) [30]. The 
expression of the targeted genes were normalised using the geometric average of three house-
keeping genes (B2M, GAPDH and β-actin) [31]. 
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Statistical analysis 
One-Way ANOVA followed by Tukey’s multiple comparison tests were used to compare 
differences in the mean %BIC, %BA, %MAR and relative gene expression between the 
implant surfaces (machined vs rough) and within each treatment group (SHAM vs OVX) at 
all-time points. A p-value of <0.05 was considered significant. 
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7.4 Results  
Analysis of early healing. 
After 3 days of healing, the cryo-fractured samples showed that more tissue was attached 
to the rough surfaced implants compared with the machined implants in both the SHAM and 
OVX groups (Fig. 2a, d; Fig. 3a, d). At high magnification, the rough surfaced implants were 
seen to be covered by a layer of mixed tissue including matrix, fibres and cells (blood and 
inflammatory cells) (Fig. 2b; Fig. 3b). However, on the machined implants, most of the 
surface was exposed or covered with a very thin mixed structure consisting of fibres and 
scattered cells with less amorphous matrix (Fig. 2e; Fig. 3e). 
 
 
 
 
 
 
 
 
 
Fig. 2  Cryo-fracture SEM and histology images of implants  after 3 days of healing in the OVX 
group. The moderately-rough surfaced implant showed more adherent mixed tissue compared to the 
smooth implant (a, b vs d, e), the attached mixed tissue include fibres, cells and amorphous matrix (b). 
The smooth implant was covered with a thinner layer of tissue with clear fibres and cells (e).  
Histological analysis showed the moderately-rough surfaced implant had osteoblasts organised near 
the old bone surface ((c), yellow arrows) compared with the smooth surface (f). ((c, f) bar=80μm). 
 
The morphology of the tissue covering the implant surfaces (rough & machined) in the 
SHAM group revealed a denser quality of fibres compared with the OVX group (Fig. 3b vs 
Fig. 2b; Fig. 3e vs Fig. 2e). Inflammatory cells were visible on the surface of the implants in 
both the OVX and SHAM groups at this early stage of healing (Day 3).  
 The effects of osteoporosis and implant topography on osseointegration in the rat maxilla        Page  122 
 
Histological analysis revealed a small amount of early osseointegration in SHAM treated 
animals with rough surfaced implants, with a thin layer of new bone seen to be forming 
directly on the implant surface (Fig.3c). However, overall there was no obvious difference 
between the SHAM and OVX group for both rough and machined implants at this early time-
point (Fig. 2c, f; Fig. 3c, g).  
 
 
 
 
 
 
 
 
 
 
Fig. 3 Cryo-fracture SEM and histology images of implants  after 3 days of healing in the SHAM 
group. The moderately-rough surfaced implant again had more adherent tissue than the smooth surface 
(a, b vs d, e), which is consistent with the OVX results ( Fig. 2). However, the tissue’s quality, especially 
the fibres in the SHAM group appears to be better than the OVX group (Fig. 3b vs Fig. 2b; Fig. 3e vs Fig. 
2e). Inflammatory cells are easily visible at this stage ((e), purple arrow). Histological images show the 
earliest osseointegration was seen in the SHAM moderately-rough surface implant ((d), orange arrow). (c, 
f, bar=80μm) 
 
The host bone was in contact with the implants in some areas, with fragments of old bone 
also sparsely distributed within the implant thread chambers. Osteoblasts were found to be 
present at this stage and were more obvious on the rough surfaced implants, especially in 
OVX animals, which showed osteoblasts regularly organized near the old bone surface (Fig. 
2c).  
Confocal fluorescence analysis at day 3 showed there was scattered new bone formation 
in the implant chamber areas as shown by the uptake of calcein fluorescence by the new bone 
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(Fig. 4). Furthermore, the SHAM group were found to have more new bone formation than 
the OVX group, while rough surfaced implants in the OVX group have better new bone 
formation than machined surfaced implants in OVX animals (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Calcein and Alizarin red staining of new bone formation. Confocal imaging revealed new bone 
formation in SHAM group implants and OVX rough surface implant (green fluorescence ) . However,  
compared with the SHAM group, new bone formed in the OVX group is limited, which indicates early 
osteogenesis could be inhibited by ovariectomy.  OVX smooth surface implants showed almost no new 
bone formation at this stage. (Bar=50μm) 
 
By day 7 of healing, under SEM observation, the rough surfaced implants were again 
found to have more mixed tissue than the machined implants. The tissue attached to the 
implant surfaces also seemed denser than it appeared at day 3 [Fig. 5a, d; Fig. 6a, e]. Under 
high magnification, fibers merged with each other to become thicker compared with their 
morphology at day 3 in both the SHAM and OVX groups. The fiber distribution in the 
SHAM group implants was thicker and more regular than the OVX group implants [Fig. 6b 
vs Fig. 5b; Fig. 6f vs Fig. 5e]. The rough surfaced implant group also showed more attached 
fibers than the machined implant group [Fig. 5b vs 5e; Fig. 6b vs 6f]. Osteoclast-like cells 
could be readily observed among the tissues associated with the OVX rough surfaced 
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implants [Fig. 5b].  Blood and inflammatory cells decreased compared with day 3 but still 
can be observed especially on the OVX machined implants [Fig. 5e].  
 
 
 
 
 
 
 
 
 
 
Fig. 5  Cryo-fracture SEM and histology images at day 7 in OVX group. Moderately-rough surface 
implants continued to attach more tissue than the smooth surface implant. The attached tissue became 
more compact and the fibres merged with each other at this stage compared with day 3 results (Fig. 2).  
OVX rough surface implant attached more tissue than smooth surface implant, with more osteoclast-like 
cells attached on the implant surface (b, green arrow);  relative more blood and inflammatory  cells can 
still  been seen in the smooth surface implant (e, purple arrow).  Histology images showed the rough 
surface implant with more osseointegration than smooth surface implant,  both ostoblasts and osteoclasts 
are visible. ((c, f) bar=80μm)      
 
Histology showed that new woven bone was formed around both machined and rough 
surfaced implants. The SHAM group formed more bone to implant contact than the OVX 
group (Fig. 6c vs Fig. 5c; Fig. 6g vs Fig. 5f), and the rough surfaced implant group showed 
more osseointegraton than the machined surfaced implant group (Fig. 5c vs 5f; Fig. 6c vs 6g). 
The new bone formed in the SHAM rough surfaced implant group seemed more mature than 
in either the SHAM machined or both OVX groups (Fig. 5c). New bone formation was also 
observed at the junction of the old bone surface in all groups. Both osteoblast and osteoclast 
activity can be observed, with osteoblasts arranged regularly along the new bone surface (Fig. 
6d), and multinuclear osteoclasts located in the old bone surface within obvious bone 
resorption pits (Fig. 6h). 
 The effects of osteoporosis and implant topography on osseointegration in the rat maxilla        Page  125 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6  Cryo-fracture SEM and histology images of day 7 results in the SHAM group.  More tissue 
was attached to the Rough surface than the smooth surface implant.  SHAM rough surface showed 
attached regular merged fibres, with less mixed cells than smooth surface implant (Fig. a, b vs  e, f).  The 
SHAM group attached tissue clearly showed better quality than OVX group (Fig. 6b vs Fig.5b; Fig. 6f vs 
Fig. 5e ). Histology images showed the SHAM rough surface implant not only has more osseointegration  
than smooth surface implant,  but also has the most mature bone compared with SHAM smooth implant 
(g) and OVX group implants (Fig. 5c, f). Both osteoblasts and osteoclasts are visible. (d, h, bar=80μm;  d, 
h, bar= 60 μm. Yellow arrows show the new bone quality,  orange arrows show the osteoblasts and blue 
arrows show the osteoclasts  )     
 
Gene expression.  
Two time points (day 3 and day 7) were selected for gene expression analysis of the early 
healing events. Gene markers were divided into four groups: osteogenic (ALP, OC and COL-
1A), osteoclast (RANKL and TRAP), osteocyte (DMP1 and SOST) and inflammation (TNFa 
and IL1b). At day 3, overall low levels of osteogenic (ALP, OC and COL1A), osteoclast 
(TRAP) and osteocyte (DMP1) gene expression was shown to be significantly higher on the 
SHAM rough surfaced implant when compared to the other groups. Osteoclast (RANKL) 
gene expression was also significantly increased in the OVX rough surfaced implant group 
(Fig. 7) Furthermore, expression of the osteocyte marker DMP1 was significantly increased 
in both SHAM and OVX rough surfaced implant group when compared with the machined 
implant groups.  
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By day 7, gene expression of ALP, OC, COL-1, RANKL, TRAP, DMP1 and SOST were 
all significantly increased in all groups when compared with the day 3 results. The osteogenic 
marker COL1A was significantly higher in the SHAM groups compared with the OVX 
groups. The osteoclast markers RANKL and TRAP were significantly increased in the 
SHAM rough surfaced implant group compared with other groups (Fig 7). Most noticeably, it 
is the TRAP rather than RANKL expression in the OVX rough surfaced implant group that 
showed significantly increased levels when compared with the corresponding day 3 result. 
The osteocyte markers, DMP1 and SOST also showed a trend towards increased levels at this 
stage. The inflammation markers IL1b and TNFa at 7 days showed decreased expression than 
at day 3, although this was not statistically significant [Fig. 7]. 
 
 
Fig. 7 Gene expression analysis of early bone and inflammatory markers. At day 3, ALP, OC, 
COL1A ,TNFa, DMP1 and TRAP were significantly increased in the SHAM rough surface implant. 
RANKL and DMP1 were also significantly increased in the OVX rough surface implant. At day 7, 
COL1A gene expression was significantly increased in SHAM group than OVX group. At the same time 
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point, the SHAM rough surface implant showed significant increase in RANKL, TRAP compared with 
other groups. 
 
 
Analysis of late healing. 
Histological analysis was also performed on the day 14 and day 28 samples.  At day 14, 
there was a significant amount of new bone around all implants for both SHAM and OVX 
groups, with active osteoclasts and osteoblasts visible. The osteoblasts were arranged 
regularly around the new bone surface, while in some areas of the old bone, multinuclear 
osteoclasts could be observed in resorption pits (Fig. 8). There was no difference in %BIC 
between the SHAM rough surfaced implant group and the SHAM machined implant group. 
In addition, no difference in the %BIC was found between the SHAM rough surfaced implant 
group and the OVX rough surfaced implant group (Fig. 9c, f). The OVX machined implant 
group had the least osseointegration as measured by %BIC, when compared with the OVX 
rough surfaced implant group and SHAM machined implant group. However, there were no 
significant differences in %BA among the groups (Fig. 8, Fig. 9c, f). 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Histology results at day 14. New bone was formed around the implant in all groups. SHAM 
group implant and OVX rough surface implant showed more osseintegration than the OVX smooth 
surface implant (Fig.9c). Both Osteoblasts (yellow arrows) and ostoeclasts (blue arrows) are active at this 
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stage. However, the OVX smooth surface implant shows more osteoclasts ( a, b, d, e, bar=100μm;  c, f, 
bar=60 μm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Histology results at day 28. The new bone appears more mature than at day 14 (Fig. 8). Active 
osteoblasts can still be seen on the new bone surface; however, osteoclast numbers appear to be lower 
compared with the day 14 results. While %BIC was significantly lower in the OVX smooth group at day 
14, the effect of OVX was not apparent in the rough group which was similar to that seen for the SHAM 
groups. By day 28, there were few significant differences in either %BIC or %BA between all the groups 
(c, f) ( a, b, d, e, bar=100μm) 
 
 
At day 28, the new bone formed around the implants had a more mature and dense 
morphology than at day 14. The %BIC for all groups increased, however only the OVX 
groups (rough and machined) were statistically higher compared to day 14.  
Comparing %BIC in the rough and machined groups (SHAM c.f. OVX) there were no 
significant differences at this time. Furthermore, there was also no significant difference 
between the SHAM and OVX groups (rough c.f. machined). The %BA values also showed a 
similar trend increasing at day 28 compared with day 14 which was statistically significant 
for SHAM rough surfaced implants. Furthermore the %BA in the SHAM rough surfaced 
implant group was significantly higher compared with the OVX rough surfaced implant 
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group at this time (Fig. 9). Osteoblasts were still visible around the new bone surface 
however the number appeared fewer than at day 14. The mineralized apposition rate (MAR) 
as determined by fluorescence staining did not show any significant differences among the 
groups (Fig. 10). 
 
 
 
 
 
 
 
Fig 10. Calcein and Alizarin red staining of new bone formation at  day 28 (a,b). There was no 
difference in the mineralized apposition rate (MAR) between groups (c). 
 
7.5 Discussion 
The effect of osteoporosis on the osseointegration of titanium dental implants continues 
to be a controversial issue [10, 11]. As most osteoporotic animal models have utilized long 
bones, such as the tibia [12, 14, 16, 32, 33] or femur [15, 34], the results from these studies is 
of limited value in understanding the osseointegration of endosseous implants into the jaw in 
osteoporotic conditions. Compared with long bone, the jaw bone has a different 
embryological origin and a different ossification mechanism as well as a different response to 
estrogen deficiency [35, 36].  Thus, results from animal models of osteoporosis using the 
maxilla would be more comparable to implant healing in osteoporotic patients. The results of 
this study show that both OVX and implant surface morphology affected the early healing 
events around the titanium dental implants. 
New bone formation was observed to be scattered in the implant thread chamber areas in 
the SHAM (rough and machined) and OVX rough surfaced implant groups as identified by 
calcein uptake as early as day 3 post-implantation. New bone on the implant surface was also 
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observed in the SHAM rough surfaced implant at day 3. These findings are consistent with 
those reported by Schwarz et al (2007) showing bone formation as early as the 4th day  post 
implant insertion [37]. It is noteworthy that these workers used a dog model rather than the 
rat which when compared with the dog, has a faster metabolism and hence accelerated 
healing  [38]. Although the earliest histological evidence of osseointegration was seen on the 
SHAM rough surfaced implant, it is difficult to conclude that the rough surfaced implant had 
the best osteoinductive/osteoconductive characteristics due to the limited sample size for 
histological analysis (n=2). Nevertheless, if we consider the histology results together with 
the cryo-facture analysis, which showed that the rough surfaced implants had more attached 
tissue than the machined implants, it is not unexpected that the rough surfaced implant should 
subsequently have accelerated bone formation compared to the machined implant. This is 
also consistent with previous findings that osseointegration occurs earlier on micro-rough 
surfaces via a process of ‘contact osteogenesis’ directly on the implant, while only ‘distance  
osteogenesis’ originating from the borders of the surgically prepared recipient bone bed is 
observed with machined surfaces [39]. 
Previous studies in vitro have shown that surface topography can affect cellular 
recruitment [40] and promote osteoblast differentiation in vitro [41]. The rough surfaced 
implant has been shown to increase osteoblastic cell attachment [42-44] and result in higher 
osteogenic gene expression (ALP, bone sialoprotein, OC) compared with machined implants 
[43]. Our study has also shown a significant increase in the expression of osteoblast markers 
(ALP, OC and COL1A) in the SHAM rough surfaced implant group consistent with 
previously reported data [43], which provides further evidence that the rough surfaced 
implant has a higher bone forming capacity than machined implants. However, the rough 
surfaced implant in the OVX group did not show an increase in osteogenic gene expression at 
this stage despite an increase in the number and organization of osteoblasts shown 
histologically on the OVX rough surfaced implant (compared to OVX machined group), 
which may indicate that estrogen deficiency may interfere with the bone forming process. 
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Bone remodeling is a coordinated process triggered by osteoblast and osteoclast activity. 
Osteoclasts also play an important role in the initial period after implant placement [45, 46]. 
Osteoclast activation by rough titanium surfaces in vitro has been shown to be similar to that 
of bone in vivo whereas activation is reduced by smooth titanium [47].  Furthermore, studies 
have shown that the gene expression of bone formation makers such as ALP, OC and 
collagen 1 were coupled with the increased expression of osteoclast markers [48, 49].  
Compared with the machined implants, our data showed that the SHAM rough surfaced 
implant group not only significantly increased the expression of bone formation markers such 
as ALP, OC and COL1A at day 3, but also significantly increased TRAP gene expression, 
which is consistent with these previous reports [48, 49]. Interestingly in the OVX rough 
group, the gene expression of RANKL rather than TRAP significantly increased at day 3. 
The higher expression of RANKL could promote osteoclasts maturation, differentiation and 
activation through the activated RANK\RANKL\OPG pathway [50, 51]. However expression 
of the bone formation markers did not increase suggesting the estrogen deficiency may affect 
the balance between osteoblast and osteoclast activity in the early (day 3) healing process. 
By day 7, apart from the inflammation markers which decreased as would be expected 
with the resolution of inflammation during healing, the gene expression of osteoblast, 
osteoclast and osteocyte markers were significantly elevated compared with day 3 and 
consistent with previous reports [48]. The increase in gene expression is also consistent with 
the histological and SEM observations, which showed more bone formation around the 
implants, as well as  more mature attached tissue. 
Comparing groups at day 7, the SHAM rough surfaced implants showed superior 
osteogenic capacity compared to the other groups, with gene increased expression of COL1A, 
RANKL and TRAP supported by histological and SEM observations of increased bone 
formation and tissue maturation. OVX negatively influenced osteogenesis as COL1A 
expression in the OVX groups was found to be significantly lower than in the SHAM groups, 
which is consistent with previous clinical findings that showed that high risk osteoporotic 
facture patients had lower levels of COL1A expression [54, 55]. The rough surfaced implants 
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showed some differences compared with the machined implants in the  OVX group, with 
TRAP gene expression significantly increased. Although the TRAP expression was lower 
compared to the SHAM rough surfaced implants at this time point , but it reached a similar 
expression level to SHAM machined implants. The results suggest that bone metabolism was 
enhanced around the rough surfaced compared to the machined implants in the OVX group. 
The gene expression analysis was supported by both the SEM cryo-fracture and histologic 
assessment, which showed more mature tissue attached on the implant surface and more 
osseointegration formed around the micro-rough compared with machined implants, , It is 
noteworthy that  that it is difficult to compare the %BIC between the different groups at the 7 
day timepoint because the new bone formation is still very limited. 
Recently Osteocytes have been shown to play an important role in the bone remodelling 
process, regulating both osteoblast and osteoclast activity [52, 53]. For example, osteocytes 
may regulate osteoblast activity through the Wnt/β-catenin pathway [54] and also regulate 
osteoclast activities through the RANK\RANKL\OPG pathway [55]. Osteocytes also can 
react to hormonal changes (such as estrogen deficiency), by increasing osteocytic apoptosis 
to trigger bone remodelling and resorption [56] Targeted ablation of osteocytes has been 
shown to lead to osteoporotic conditions [57]. Our previous work has shown that osteocytes 
have a close ultrastructural relationship with dental implants [58], however, the potential role 
of osteocytes in osseointegration under osteoporotic conditions is still not clear. 
The role of osteocytes in the establishment of osseointegration was also assessed. The 
key molecule DMP1 which controls osteocyte formation and phosphate homeostasis [59] was 
significantly increased on the rough surfaced implant at day 3 in both OVX and SHAM 
groups, which indicated that the rough surfaced implant may trigger an earlier osteocyte 
response than the machined implant, thus regulating both osteoblast and osteoclast activities. 
As mentioned earlier, the RANKL expression at day 3 was significantly increased in the 
OVX rough surfaced implant group. Recent research has shown that it is osteocytes rather 
than osteoblast that are the mainly source of RANKL [60, 61].  The increased RANKL and 
DMP1 gene expression in the OVX group indicated the the rough surfaced implants triggered 
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an earlier osteocytes response/bone remodeling process than machined implants, even under 
the influence of estrogen deficiency. The advantages of the rough surfaced implant were also 
supported by the SEM and histology observation.  
At day 7, both DMP1 and SOST gene expression were significant increased compared 
with day 3 which also coresponded with increased osteoblast and osteoclast gene markers, 
which indicated osteocytes regulating bone formation were in an active state. The SOST gene, 
which is a negative regulator of osteoblast function as an antagonist of the Wnt/β-catenin 
pathway, was also highly expressed compared with the day 3 results. The gradually increase 
of SOST gene expression form day 3 to day 7 suggests a transition of the osteocytes’ 
regulatory role, which at the earlier timepoint (day 3) predominantly promotes bone 
formation, and then gradually evolves into a role that balances  osteoblast and osteoclast 
activities.  
By day 14, estrogen deficiency (OVX) negatively affected the osseointegration of the 
machined implants as indicated by the low %BIC. Osseointegration of the rough surface 
implants however was relatively unaffected with the %BIC similar to that seen in the SHAM 
group, suggesting that the rough surface largely compensated for the negative effect of OVX. 
By day 28, there were no significant differences among the groups suggesting that 
sufficient healing time may also compensate for the disadvantageous effects of machined 
surface  topography or estrogen deficiency. Our results are highly consistent with another 
report which also compared three different surfaces (two different commercial rough surfaces 
c.f. a smooth surface implant) and showed significant differences only in the early healing 
time points (2 and 4 weeks). After  6 weeks of healing,  there were no significant differences 
among the groups [62]. The similarity in the degree of osseointegration between the OVX 
and SHAM  groups at this late time-point (28 days) is in agreement with previous reports 
which show no significant difference in long-term implant survival rate between rough and 
smooth surfaced implants [63] or between osteoporosis and healthy subjects [12, 64, 65].  
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Moreover, the bone area (%BA) and mineral apposition rates (MAR) did not show any 
significant difference among the two groups. These findings suggest that osteoporosis may 
primarily affect the interface areas of the implant.  
7.6 Conclusion 
Both ovariectomy and implant morphology affected the osseointegration of implants in 
the early healing stage. Osteoporosis delayed early bone healing around machined surface 
implant. However, the rough surfaced implants could compensate for the negative effect(s) of 
ovariectomy by triggering an early osteocytes/osteogenic response and thus facilitating the 
earlier osseointegration of rough implants.  
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8.1 Summary of  Research Outcomes 
      Osseointegration has been defined as a direct bone-to-implant contact without 
interposed soft tissue. A rigid, functional fixation of dental implants within the host bone site 
achieved by osseointegration is necessary to provide long-term anchorage with the ability to 
support masticatory function. The osseointegration process and consequent clinical success of 
dental implants becomes more challenging in compromised clinical situations like 
osteoporosis. However, researchers still do not fully understand the biological mechanisms 
involved in osseointegration, and the consequential effects of conditions like osteoporosis on 
this process remains obscure.        
         There are a lot of factors that influence osseointegration, amongst which systemic 
factors are considered to play an integral role. The implant and its host bone are the two 
major interacting entities, and minor changes to either entity would affect the process of bone 
formation around an implant. It is recognised that compromised bone negatively affect 
osseointegration, while a micro-rough implant surface results in superior osseointegration 
compared with a smooth surface. Many diseases and conditions may affect bone quality. 
These include disorders of bone mineral homeostasis or imbalance of bone remodelling 
diseases such as osteoporosis, diabetes mellitus, hyperparathyroidism, Cushing’s disease, 
Paget’s disease, and collagen disorders such as osteogenesis imperfecta, Marfan syndrome, 
and drugs affecting bone quality such as glucocorticoids, chemotherapeutic agents and 
bisphosphonates, among others [1]. Of these  diseases, osteoporosis is the most prevalent 
worldwide; it is estimated that over 200 million people worldwide have osteoporosis[2].  In 
Australia, the effect of this disease causes fractures in 50% of women and 33.33% of men 
beyond the age of 60 years [3]. Osteoporosis causes reduced bone formation, leading to 
fractures and impaired bone healing. The relationship between osteoporosis and bone 
formation around implants is still unclear. The consensus of the ITI (International Team of 
Oral Implantology) is that there is only a weak association with the risk of implant failure, 
however, this conclusion was based on only two-case control studies[4].  
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      Osteoporosis is a condition characterised by decreased bone mineral density and a 
deterioration of bone microarchitecture, resulting in compromised bone quality. Therefore, 
osteoporosis is an interesting model to study the effect of compromised bone quality on 
osseointergration. The ovariectomized rat is the most useful model to simulate human 
postmenopausal osteoporosis, and has been selected for this study. Existing literature remains 
inconclusive whether the jaw bone (maxilla) is affected by osteoporosis, and the clarification 
of this controversial point was one of the aims of this project.  
Published information regarding the use of rat jawbones for dental implant 
osseointegration research is also limited and inconsistent.  The recent consensus statement 
from the Eighth European workshop on preclinical in vivo research (ARRIVE guidelines) 
concluded rodents were primarily used for osseointegration research when examining the 
effects of systemic disease. However, when healthy animals were used, the predominant 
implant sites were extra-oral, i.e. tibia and femur [5].  There is an urgent need to assess the 
suitability and feasibility of placing dental implants into the rat maxilla and to establish 
parameters to be used for dental implant research using this model. Dental implant success 
relies on the process of osseointegration whereby the titanium is bound to bone tissue without 
any intervening soft tissue.[6]  However the biological mechanisms responsible have not 
been fully elucidated, especially with regard to the possible role of osteocytes in the 
maintenance of osseointegration.[7] Based on the traditional methods such as  light 
microscopy (LM),
 
Scanning electron microscopy (SEM) and Transmission electron 
microscopy (TEM) it is difficult to observe the ultrastructural of relationship between 
osteocytes and dental implants following osseointegration. A new method which can 
visualize the ultrastructure of the implant-bone interface in three-dimensions (3D) would thus 
be beneficial in facilitating the study of the relationship between bone cells and the implant 
surface. 
Additionally, the design, chemical composition and topography of the implant surface is 
known to influence peri-implant tissue healing and subsequent osseointegration [8], but 
whether a moderately rough surface compared to a smooth surface can overcome the 
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disadvantages resulting from osteoporotic conditions warrents further study. Given that 
implant therapy has a very high success rate in healthy patients with good bone quality and 
quantity, one of the major foci of current research is the performance of implants in 
compromised sites and patients. Therefore, understanding the extent to which moderately 
rough implants can overcome the negative influence of systemic conditions has a clear 
clinical relevance. 
Based on above, the first part of the project explored whether a rat’s maxilla could be 
used as an appropriate model for osteoporosis. In order to obtain a comprehensive 
understanding of maxilla changes after ovariectomy,  3 dimensional Micro CT, together with 
histological analysis, was used to analyse the changes in the maxilla, and the observation 
time points were set at 8, 12, 16 and 20 weeks. However, this is very difficult to implement 
because of the irregular shape of maxilla and tooth roots, as well as the presence of the sinus 
and nose cavities. The furcation area, which consists entirely of trabecular bone, is the most 
appropriate site to reflect the impact of osteoporosis on bone quality. Therefore, the furcation 
areas of the first molar and second molars were selected for micro CT analysis, assuming that 
any changes to the trabecular bone in the area would be representative of changes in the 
remainder of the maxilla. Significant changes were observed in the rat maxillae as early as 12 
weeks following surgery. The results also confirmed that estrogen deficiency affects the 
jawbone resulting in compromised bone quality, thus establishing the rat maxilla as an 
appropriate model to explore the bone –implant healing process in osteoporosis. 
In order to assess the effects of various parameters (such as osteoporosis and implant 
topography) on osseointegration and bone regeneration, various animal models have been 
routinely used before proceeding to human clinical trials. Small animals such as rodents 
(mice, rats, rabbits) are often used before moving to larger animal (dogs, sheep, pigs, 
primates) studies. However, published information regarding the use of rat jawbones for 
dental implant osseointegration research is also limited and inconsistent. The second part of 
the study assessed the suitability and feasibility of placing dental implants into the rat maxilla 
and to establish parameters to be used for dental implant research using this model. Forty two 
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customised titanium implants (2×3mm) were placed bilaterally in the maxillary first molar 
area of 21 Sprague-Dawley rats. Resin-embedded sections of the implant and surrounding 
maxilla were prepared for histological and histomorphometric analyses. The results showed 
the mesial root of the first molar in the rat maxilla was the optimal site to place the implant.  
28 days of healing can be considered as an appropriate end point to assess the degree of 
osseointegration as measured by percentage bone-to-implant contact (%BIC) and bone area 
(%BA). The recommended implant dimensions for this particular site in the rat is 1.5mm in 
width and 2mm in length. 
Recently, mounting evidence supports a prominent and multi-factorial role for osteocytes 
in bone homeostasis, such as as a mechanosensor perceiving strain signals through its 
dendritic processes or the bending of cilia [9-11], reacting to hormonal changes such as 
estrogen deficiency [12] and regulating mineralization [13] etc. The third part of this study 
tried to investigate the feasibility of using the resin-cast osteocyte method to observe the 
relationship between the LCN (including osteocytes) structure and the implant surface at the 
ultrastructural level in osseointegrated implant samples. The resin embedded samples were 
etched with 37% phosphoric acid and sections were coated with gold and examined using a 
Carl Zeiss SIGMA VP field emission scanning microscope. The results showed the 
osteocytes to be less organized in the newly formed bone around the titanium implant. 
Further, a layer of mineralization with less organic components was observed on the implant 
surface. This study has shown for the first time that osteocytes and their dendrites were 
directly connected with the implant surface and suggested an important regulatory role for 
osteocytes and their lacunar–canalicular network in maintaining long term osseointegration. 
The final part of the study was been designed to assess the effects of osteoporosis on 
osseointegration and whether rough surfaced implants could have some potential to overcome 
the negative effects on osseointegration due to osteoporosis. The osseointegration process 
was evaluated by both histological and scanning electron microscopy (SEM). analysis.  The 
molecular effects of estrogen deficiency on cells involved in the osseointegration process was 
also examined by assessing the expression of  bone remodelling markers using quantitative 
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real-time PCR (qPCR). This included bone formation markers such as alkaline phosphatase 
(ALP), osteocalcin (OC), alpha-1 type I collagen COL1A), osteoclast markers such as 
receptor activator of nuclear factor kappa-B ligand (RANKL) and tartrate-resistant acid 
phosphatase (TRAP), osteocyte markers such as dentin matrix protein 1 (DMP1), and 
sclerostin (SOST), and inflammatory marker gene expression tumor necrosis factor-alpha 
(TNFα) and interleukin-1β (IL-1β)).  
Osseointegration as measured by the percentage of bone to implant contact (%BIC), was 
significantly higher around rough surfaced implants in the OVX animals when compared to 
machined implants in OVX animals at DAY 14. The %BIC in the OVX rough implant group 
was similar to that seen with both rough and smooth implants in SHAM animals at this time. 
By day 28 however, similar levels of %BIC were similar for all test groups. This suggests the 
rough surface stimulated a more rapid osseointegration process in OVX animals.  
To assess the possible molecular mechanism(s) responsible for this accelerated 
osseointegration on the rough surface, the level of gene expression of osteoblast, osteocyte, 
osteoclast and inflammatory markers at day 3 and 7 were examined. At day 3 the rough 
surface implant significantly increased the expression of alkaline phosphatase (ALP), 
osteocalcin (OC), alpha-1 type I collagen (COL1A), receptor activator of nuclear factor 
kappa-B ligand (RANKL), tartrate-resistant acid phosphatase (TRAP) and dentin matrix 
protein 1 (DMP1). By day 7, the expression of the inflammatory markers was lower as 
expected with resolution of the initial inflammation at implant placement. Expression of the 
bone markers increased further overall, although there were few significant differences in the 
levels of expression comparing the rough and machined surfaces at this time. These 
molecular results correlate with the morphological (histology and SEM) observations at these 
early healing time points. OVX also reduced the osteocyte’s body size rather than its lacuna.  
In conclusion, osteoporosis was found to reduce the early osseointegration (as measured 
by %BIC) of machined implants. However, the rough surfaced implant appeared to trigger a 
cell response able to compensate for the estrogen deficient conditions resulting in %BIC 
similar to that seen in SHAM animals. Nevertheless, this difference was not maintained as 
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there was no significant difference in %BIC between the OVX and SHAM groups regardless 
of implant surface in the long-term (day 28).   
 
8.2 Major Contributions 
This project observed the effects of osteoporosis and implant morphology on the 
osseointegration. The ovariectomised rat is a frequently used model for osteoporosis as 
recommended by the U.S. Food and Drug Adminstration (FDA) [14]. However, whether the 
rat’s maxillary and/or mandibular bone can be used to study osteoporotic bone loss compared 
with the routinely used long bones or vertebrae is still a controversial issue [15] due to the 
different endochondral and membranous bone formation between long bones and 
maxillar/mandibular bones [16]. The maxilla is an irregularly shaped bone due to the 
presence of the sinus and nasal cavity in the molar area, which makes the micro CT analysis 
challenging. We created a novel method to analyse the representative furcation area among 
the roots to resolve this issue perfectly. 
How to place the implant into maxilla was also a challenge for the project. Information 
about implant placement into the maxilla is confused with insufficient data reported in the 
literature. We found the mesial root socket of the first molar in the rat maxilla is a useful 
model for dental implant research.  
Osseointegration is a key word for this project. However knowledge about 
osseointegration has been mainly acquired from microscopic observation. This research 
developed a novel methodology to visual the 3-D relationship of osteocytes and the implant 
which will benefit the future research on the potential role of osteocytes in osseointegration.  
Based on the above animal model platform, we further observed the effects of 
osteoporosis and implant surface topography on osseointegration. We found estrogen 
deficiency only affected the early implant healing and the implant morphology also affected 
the implant early healing process.  
Briefly, the major findings of the thesis are as follows: 
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1 We created a new method to estimate the irregular maxilla bone density changes 
under estrogen deficiency. 
2 We demonstrated the mesial root socket of rat maxilla can be used a model for dental 
implant research. 
3 We created a novel method to observe the 3-D relationship between osteocytes and 
the implant surface. 
4 We showed estrogen deficiency only affected the implant early heling period and the 
rough surfaced implant can overcome this negative effect.   
 
8.3 Limitations &Recommendations for Future Work 
The first part of our research proved the rat’s maxilla is a good model for osteoporosis 
research. This conclusion was based on the 3-D micro CT analysis. However, this method 
was based on an analysis of the furcation area only. While we believe that this area is 
representative of the whole maxilla, analysis of whole maxilla is difficult because of the 
technology involved. Further work is therefore needed to find a new method to analyse the 
whole maxilla rather than just one area.   
In the second part, we found the mesial root socket of the first molar in the rat maxilla is 
a useful model for dental implant research. However, the implant placement operation 
requires a high degree of skill which is a limiting factor. Furthermore the implant used for 
this model is only suitable for small animal use.  Compared with the generally used 
commercial implant for humans, this is a clear limitation of the study. Future work in a large 
osteoporotic animal model using commercial implants is also required.  
In third part of our research, we found osteocytes had a close relationship with the dental 
implant. In terms of the multi-factorial role for osteocytes in bone homeostasis, osteocytes 
may react to hormonal changes such as estrogen deficiency, which through an increase in 
osteocyte apoptosis, triggers bone remodeling and resorption. Osteocytes may also play a role 
in mineral (phosphate) regulation and biomineralizaton via the action of osteocyte-specific 
proteins such as PHEX, DMP-1, MEPE, and FGF-23. It has also been shown that osteocytes 
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play a very important role in bone remodeling through the actions of the Wnt/β-catenin 
pathway regulators Dkk1 and sclerostin, both of which are highly expressed in osteocytes.  
Further work is required to link the ultrastructural relationship observed between osteocytes 
and the implant in this study with a functional role in bone formation around implants as well 
as the osteocytes changes caused by compromised bone environment. 
The final part of our research suggested estrogen deficiency affects the jaw bone and the 
early healing of machined implants. Rough implants also showed faster (earlier) 
osseointegration compared with other groups although ultimately this difference between 
machined and rough surface implants was not maintained. How and why estrogen deficiency 
only affected the early implant healing periods and the exact mechanisms involved are still 
not totally understood, and deserve further research.  
Finally, as this work is based on a small animal model, further work is needed using a 
larger animal model to confirm whether the results of this study are likely to be consistent 
with those in human subjects. 
 
8.4 Closing Remarks 
In conclusion, rat maxilla has proved to be a good model for osteoporosis research as 
well as a good model for dental implant research. Based on this model, we found osteocytes 
have a closed relationship with dental implant which indicated osteocytes may play an 
important role in the osseointegraton remodelling process. Osteoporosis was found to reduce 
the early osseointegration (as measured by %BIC) of the machined implant. However, the 
rough surfaced implant appeared to trigger an earlier cell response able to compensate for the 
estrogen deficient conditions resulting in %BIC similar to that seen in SHAM animals. 
Nevertheless, this difference was not maintained as there was no significant difference in 
osseointegration between the OVX and SHAM groups in the long-term. 
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Chapter 4   Micro Ct data tables for Tibia and maxilla molars 
 
 
Table 1  Micro CT results of tibia  
 OVX SHAM 
 BV/TV (%) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm
-1
) Conn.Dens 
(1/mm
3
) 
BV/TV (%) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm
-1
) Conn.Dens 
(1/mm
3
) 
8W 
0.036±0.060
*
 
0.060±0.004 
0.980±0.368
*
 1.174±0.439
*
 6.413±4.126
*
 
0.148±0.038 0.067±0.006 0.284±0.054 3.592±0.611 58.787±17.926 
12W 
0.031±0.010
*
 
0.067±0.004 
1.324±0.307
*
 0.801±0.178
* 3.970±2.668* 0.117±0.032 0.063±0.005 0.368±0.098 2.903±0.620 44.853±15.711 
16W 
0.030±0.010
*
 
0.073±0.009 
1.385±0.331
*
 0.776±0.228
*
 3.849±1.741
*
 
0.126±0.033 0.064±0.005 0.362±0.121 3.036±0.847 50.022±15.735 
20W 
0.032±0.011
*
 
0.079±0.011 
1.598±0.330
*
 0.667±0.118
*
 3.782±2.359
*
 
0.155±0.018 0.070±0.005 0.305±0.053 3.368±0.538 57.221±7.618 
Micro CT results of tibia showed significant differences from 8 weeks for the parameters BV/TV , TbSp. , Tb.N., and Conn.dens separately. (* P< 0.05) 
 
Table 2  Micro CT results of first molar 
 OVX SHAM 
 BV/TV (%) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm
-1
) Conn.Dens 
(1/mm
3
) 
BV/TV (%) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm
-1
) Conn.Dens 
(1/mm
3
) 
8W 0.921±0.024 0.214±0.025 0.063±0.009 7.057±0.447 
52.219±13.486
*
 
0.947±0.023 0.241±0.031 0.065±0.018 6.681±0.776 31.317±11.958 
12W 
0.658±0.024
*
 0.235±0.032
*
 0.250±0.027
*
 3.625±0.277
*
 
16.051±6.246 0.867±.038 0.272±0.028 0.131±0.027 5.160±0.483 21.449±8.023 
16W 
0.602±0.100
*
 0.166±0.035
*
 0.237±0.059
*
 4.163±0.492
*
 44.745±22.034
*
 
0.817±0.106 0.250±0.045 0.172±0.068 4.790±0.486 17.649±5.835 
20W 
0.672±0.082
*
 0.209±0.024
*
 0.220±0.022
*
 
4.296±0.357 22.343±9.126 0.798±0.098 0.257±0.034 0.172±0.069 4.363±0.467 22.331±11.117 
Micro CT results of first molar showed significant differences from 12 weeks for the parameters BV/TV , Tb.Sp , Tb.Th and Tb.N . (* P< 0.05)  Note the difference between the 
results for Tb.Th between the maxilla here and the tibia (table 1). 
 
 
 
 
  
 
 
 
Table 3  Micro CT results of second molar 
 OVX SHAM 
 BV/TV (%) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm
-1
) Conn.Dens 
(1/mm
3
) 
BV/TV (%) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm
-1
) Conn.Dens 
(1/mm
3
) 
8W 0.894±0.046 0.223±0.014 0.076±0.018 6.977±1.063 47.969±16.390 0.847±0.051 0.215±0.026 0.090±0.027 7.099±0.583 57.912±4.937 
12W 
0.539±0.057
*
 
0.215±0.026 
0.319±0.056
*
 3.393±0.446
*
 
20.077±6.906 0.724±0.063 0.228±0.035 0.188±0.040 5.330±0.696 32.967±13.171 
16W 
0.547±0.114
*
 0.182±0.026
*
 0.223±0.053
*
 
4.498±0.653 
58.075±7.955
*
 
0.971±0.765 0.253±0.049 0.164±0.058 4.683±0.579 28.934±9.401 
20W 
0.517±0.712
*
 0.165±0.015
*
 0.256±0.050
*
 4.206±0.509
*
 51.926±8.467
*
 
0.810±0.103 0.254±0.058 0.148±0.066 5.303±0.758 23.155±10.145 
Micro CT results of second molar showed significant differences between the groups for the parameters BV/TV, Tb.Sp, and Tb.N. from 12 weeks after surgery.  
For Tn.Th , the difference between the groups was statistically significant from 16 weeks. Note the difference of index Tb.Th compared with tibia (table 1). (* P< 
0.05) 
 
 
 
 
 
 
 
  
 
Chapter 7   Table 1 Premer sequences used for real-time PCR 
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